Patent Grant
11058334
Patents, applications and/or publications described herein, including the following patents, applications and/or publications are incorporated herein by reference for all purposes: U.S. Pat. Nos. 4,545,382; 4,711,245; 5,262,035; 5,262,305; 5,264,104; 5,320,715; 5,356,786; 5,509,410; 5,543,326; 5,593,852; 5,601,435; 5,628,890; 5,820,551; 5,822,715; 5,899,855; 5,918,603; 6,071,391; 6,103,033; 6,120,676; 6,121,009; 6,134,461; 6,143,164; 6,144,837; 6,161,095; 6,175,752; 6,270,455; 6,284,478; 6,299,757; 6,338,790; 6,377,894; 6,461,496; 6,503,381; 6,514,460; 6,514,718; 6,540,891; 6,560,471; 6,579,690; 6,591,125; 6,592,745; 6,600,997; 6,605,200; 6,605,201; 6,616,819; 6,618,934; 6,650,471; 6,654,625; 6,676,816; 6,730,200; 6,736,957; 6,746,582; 6,749,740; 6,764,581; 6,773,671; 6,881,551; 6,893,545; 6,932,892; 6,932,894; 6,942,518; 7,041,468; 7,167,818; and 7,299,082; 7,381,184; 7,740,581; 7,811,231 U.S. Published Application Nos. 2005/0182306, now U.S. Pat. No. 8,771,183; 2006/0091006; 2007/0056858, now U.S. Pat. No. 8,298,389; 2007/0068807, now U.S. Pat. No. 7,846,311; 2007/0095661; 2007/0108048, now U.S. Pat. No. 7,918,975; 2007/0149873, now U.S. Pat. No. 9,014,773; 2007/0149875, now U.S. Pat. No. 8,515,518; 2007/0199818, now U.S. Pat. No. 7,811,430; 2007/0227911, now U.S. Pat. No. 7,887,682; 2007/0233013; 2008/0058625, now U.S. Pat. No. 7,920,907; 2008/0064937; 2008/0066305, now U.S. Pat. No. 7,895,740; 2008/0071157; 2008/0071158; 2008/0081977, now U.S. Pat. No. 7,618,369; 2008/0102441, now U.S. Pat. No. 7,822,557; 2008/0148873, now U.S. Pat. No. 7,802,467; 2008/0161666; 2008/0179187, now U.S. Pat. No. 8,808,515; 2008/0267823; 2008/0319295, now U.S. Pat. No. 8,597,188; 2008/0319296, now U.S. Pat. No. 8,617,069; 2009/0018425, now U.S. Pat. No. 8,160,670; 2009/0247857, now U.S. Pat. No. 8,346,335; 2009/0257911, now U.S. Pat. No. 8,252,229, 2009/0281406; 2009/0294277; 2009/0054748, now U.S. Pat. No. 7,885,698; 2009/0054749; 2010/0030052; 2010/0065441, now U.S. Pat. No. 8,636,884; 2010/0081905, now U.S. Pat. No. 8,983,568; 2010/0081909, now U.S. Pat. No. 8,219,173; 2010/0213057; 2010/0325868, now U.S. Pat. No. 7,866,026; 2010/0326842; 2010/0326843, now U.S. Pat. No. 8,437,827; 2010/0331643; 2011/0046466; U.S. patent application Ser. No. 12/624,767, now U.S. Patent Publ. No. 2011/0124993; Ser. No. 12/625,185, now U.S. Pat. No. 8,354,013; Ser. No. 12/625,208, now U.S. Pat. No. 9,042,954; Ser. No. 12/625,524, now U.S. Pat. No. 8,390,455; Ser. No. 12/625,525, now U.S. Pat. No. 8,358,210; Ser. No. 12/625,528, now U.S. Pat. No. 8,115,635; Ser. No. 12/628,177, now U.S. Patent Publ. No. 2010/0076289; Ser. No. 12/628,198, now U.S. Patent Publ. No. 2010/0076291; Ser. No. 12/628,201, now U.S. Patent Publ. No. 2010/0076280; Ser. No. 12/628,203, now U.S. Patent Publ. No. 2010/0076292; Ser. No. 12/628,210, now U.S. Patent Publ. No. 2010/0076293; Ser. No. 12/698,124, now U.S. Patent Publ. No. 2010/0198034; Ser. No. 12/698,129, now U.S. Patent Publ. No. 2010/03243925; Ser. No. 12/699,653, now U.S. Patent Publ. No. 2010/0198142; Ser. No. 12/699,844, now U.S. Pat. No. 8,930,203; Ser. No. 12/714,439, now U.S. Patent Publ. No. 2010/0230285; Ser. Nos. 12/730,193; 12/794,721, now U.S. Pat. No. 8,595,607; Ser. No. 12/807,278, now U.S. Patent Publ. No. 2011/0213225; Ser. No. 12/842,013, now U.S. Patent Publ. No. 2011/0021889; Ser. No. 12/870,818, now U.S. Patent Publ. No. 2011/0073475; Ser. No. 12/871,901, now U.S. Pat. No. 8,514,086; Ser. No. 12/873,301, now U.S. Patent Publ. No. 2011/0054275; Ser. No. 12/873,302, now U.S. Patent Publ. No. 2011/0060196; Ser. No. 13/011,897, now U.S. Patent Publ. No. 2011/0184265; and U.S. Provisional Application Nos. 61/238,646; 61/246,825; 61/247,516; 61/249,535; 61/317,243; 61/325,155; 61/345,562; and 61/359,265.
The detection and/or monitoring of glucose levels or other analytes, such as lactate, oxygen, A1C, or the like, in certain individuals is vitally important to their health. For example, the monitoring of glucose is particularly important to individuals with diabetes. Diabetics generally monitor glucose levels to determine if their glucose levels are being maintained within a clinically safe range, and may also use this information to determine if and/or when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.
Growing clinical data demonstrates a strong correlation between the frequency of glucose monitoring and glycemic control. Despite such correlation, many individuals diagnosed with a diabetic condition do not monitor their glucose levels as frequently as they should due to a combination of factors including convenience, testing discretion, pain associated with glucose testing, and cost.
Devices have been developed for the automatic monitoring of analyte(s), such as glucose, in bodily fluid such as in the blood stream or in interstitial fluid (“ISF”), or other biological fluid. Some of these analyte measuring devices are configured so that at least a portion of the devices are positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user, so that the monitoring is accomplished in vivo.
With the continued development of analyte monitoring devices and systems, there is a need for such analyte monitoring devices, systems, and methods, as well as for processes for manufacturing analyte monitoring devices and systems that are cost effective, convenient, and with reduced pain, provide discreet monitoring to encourage frequent analyte monitoring to improve glycemic control.
An apparatus for inserting a medical device at least partially through the skin of a subject is provided, which includes a first subassembly and a second subassembly. The first subassembly includes a sheath defining a distal surface for placement on the skin of the subject, a handle movable between a proximal position and distal position, a device support for supporting the medical device and defining an aperture therethrough, the device support coupled to the handle, a sharp support for supporting a sharp extending through said aperture and coupled to the device support, and a first driver for biasing the sharp support towards the proximal position. The second subassembly includes a housing configured for removable attachment to the first subassembly, and a second driver for advancing the sharp support towards the distal position.
In some embodiments, the first subassembly and the second subassembly are modular components. In some embodiments, the first subassembly is capable of independent operation without the second subassembly. In some embodiments, the driver of the first subassembly is capable of operation by a user without the second subassembly. In some embodiments, the driver of the first subassembly is actuable by depressing an actuation switch or button. In some embodiments, the second subassembly is configured to actuate the actuation switch or button of the first subassembly.
In some embodiments, the second driver includes a rotatable cam or a torsion spring. In some embodiments, the second driver includes either an axial driver and a crank assembly or a compression spring. In some embodiments, the first driver includes a compression spring, or a torsion spring.
In some embodiments, the handle is at least partially disposed surrounding the sheath. In some embodiments, a retention member for retaining the device support in the distal position is provided. The device support may be coupled to the handle until the device support reaches a distal position.
In some embodiments, the first subassembly is configured for a single use. In some embodiments, the second subassembly is configured for multiple uses.
Embodiments of analyte sensors are provided which include a body having a proximal section and a distal section. The distal section may be longitudinally aligned with the proximal section. An intermediate section may be included between the proximal and distal sections, and in some embodiments the intermediate section is laterally displaced from at least the distal member.
In some embodiments, the proximal end is received within a needle seat to create an anchor region to allow the sensor body to slide into an opening defined in the insertion sharp but prevent the sensor body from inadvertently slipping out of the insertion needle. In some embodiments, a width of the distal section of the sensor body is sized to fit within the opening of the insertion sharp. In certain embodiments, the opening in the sharp has a diameter of about 20 gauge to about 26 gauge, e.g., 21 gauge to about 25 gauge, where in certain embodiments the sharp is 21 gauge or 23 gauge or 25 gauge. Such sharp may be used with a sensor having a width or diameter—at least the portion that is carried by the sharp—of about 0.20 mm to about 0.80 mm, e.g., about 0.25 mm to about 0.60 mm, where in some embodiments the width or diameter of least a portion of a sensor is 0.27 mm or 0.33 mm or 0.58 mm.
In some embodiments, the intermediate member includes a plane-altering portion. The plane-altering portion allows the proximal section of the sensor body to be in a plane different than the distal section of the sensor body. In some embodiments, the proximal section and the distal section are in planes substantially perpendicular to each other, e.g., the area may define an angle of about 120° to about 60°, e.g., about 90°.
In certain embodiments, apparatuses for inserting a medical device at least partially through the skin of a subject are provided which include a sheath defining a distal surface for placement on the skin of the subject; a handle movable between a proximal position and distal position; a device support for supporting the medical device and defining an aperture therethrough, the device support coupled to the handle; a sharp support for supporting a sharp extending through said aperture and coupled to the device support; and driver for biasing the sharp support towards the proximal position.
In some embodiments, the driver includes a compression spring. In some embodiments, the handle is at least partially disposed surrounding the sheath. In some embodiments, a stop portion for retaining the device support in the distal position is included. In some embodiments, the device support is coupled to the handle until the device support reaches a distal position. In some embodiments, the device support is uncoupled from the sharp support when the device support reaches the distal position.
In some embodiments, a second assembly interfaces with the insertion devices or first subassembly. The second assembly automates the insertion segment motion of the described inserter. The second assembly may include a housing configured for removable attachment to the first subassembly, a handle configured for longitudinal movement with respect to the housing, an actuator configured for longitudinal movement with respect to the housing, a release member either located on the actuator or handle which is actuated upon the handle reaching a predetermined position, a driver element coupled between the handle and the actuator, energized upon distal movement of the handle, which drives the actuator distally once the release member is actuated, and a second driver which is also energized upon distal movement of the handle, that applies a proximal force on the handle that returns the handle to a proximal position after pressure is relieved from the handle post insertion. The second driver, coupled through the handle, also provides a proximal force to return the actuator to its proximal position where the release member is reengaged.
In some embodiments, the first driver includes a compression spring, or a torsion spring. In some embodiments, the handle is at least partially disposed surrounding the sheath. In some embodiments, a retention member for retaining the device support in the distal position is provided. The device support may be coupled to the handle until the device support reaches a distal position.
In some embodiments, the first subassembly is configured for a single use. In some embodiments, the first subassembly is configured for multiple uses. In some embodiments, the second subassembly is configured for multiple uses.
These and other features, objects, and advantages of the disclosed subject matter will become apparent to those persons skilled in the art upon reading the detailed description as more fully described below.
A detailed description of various aspects, features, and embodiments of the subject matter described herein is provided with reference to the accompanying drawings, which are briefly described below. The drawings are illustrative and are not necessarily drawn to scale, with some components and features being exaggerated for clarity. The drawings illustrate various aspects and features of the present subject matter and may illustrate one or more embodiment(s) or example(s) of the present subject matter in whole or in part.
A detailed description of the disclosure is provided herein. It should be understood, in connection with the following description, that the subject matter is not limited to particular embodiments described, as the particular embodiments of the subject matter may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the disclosed subject matter will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value between the upper and lower limit of that range, and any other stated or intervening value in that stated range, is encompassed within the disclosed subject matter. Every range stated is also intended to specifically disclose each and every “subrange” of the stated range. That is, each and every range smaller than the outside range specified by the outside upper and outside lower limits given for a range, whose upper and lower limits are within the range from said outside lower limit to said outside upper limit (unless the context clearly dictates otherwise), is also to be understood as encompassed within the disclosed subject matter, subject to any specifically excluded range or limit within the stated range. Where a range is stated by specifying one or both of an upper and lower limit, ranges excluding either or both of those stated limits, or including one or both of them, are also encompassed within the disclosed subject matter, regardless of whether or not words such as “from,” “to,” “through,” or “including” are or are not used in describing the range.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosed subject matter belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosed subject matter, this disclosure may specifically mention certain exemplary methods and materials.
All publications mentioned in this disclosure are, unless otherwise specified, incorporated by reference herein for all purposes, including without limitation to disclose and describe the methods and/or materials in connection with which the publications are cited.
The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosed subject matter is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates, which may need to be independently confirmed.
As used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise.
Nothing contained in the Abstract or the Summary should be understood as limiting the scope of the disclosure. The Abstract and the Summary are provided for bibliographic and convenience purposes and due to their formats and purposes should not be considered comprehensive.
As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosed subject matter. Any recited method can be carried out in the order of events recited, or in any other order which is logically possible.
Reference to a singular item includes the possibility that there are plural of the same item present. When two or more items (for example, elements or processes) are referenced by an alternative “or,” this indicates that either could be present separately or any combination of them could be present together except where the presence of one necessarily excludes the other or others.
Generally, embodiments of the present disclosure relate to an apparatus for inserting a medical device at least partially into the skin of the patient. Some embodiments relate to in vivo methods and devices for detecting at least one analyte such as glucose in body fluid. Accordingly, embodiments include in vivo analyte sensors configured so that at least a portion of the sensor is positioned in the body of a user (e.g., within the ISF), to obtain information about at least one analyte of the body, e.g., transcutaneously positioned in user's body. In certain embodiments, an in vivo analyte sensor is coupled to an electronics unit that is maintained on the body of the user to process information obtained from the sensor.
In certain embodiments, analyte information is communicated from a first device such as an on body electronics unit to a second device which may include user interface features, including a display, and/or the like. Information may be communicated from the first device to the second device automatically and/or continuously when the analyte information is available, or may not be communicated automatically and/or continuously, but rather stored or logged in a memory of the first device. Accordingly, in many embodiments of the system, analyte information derived by the sensor/on body electronics (for example, on body electronics) is made available in a user-usable or viewable form only when queried by the user such that the timing of data communication is selected by the user. In some embodiments, the display of information is selected by the user, while the timing of data communication is not.
In this manner, analyte information is only provided or evident to a user (provided at a user interface device) in some embodiments when desired by the user even though an in vivo analyte sensor automatically and/or continuously monitors the analyte level in vivo, i.e., the sensor automatically monitors analyte such as glucose on a pre-defined time interval over its usage life. For example, an analyte sensor may be positioned in vivo and coupled to on body electronics for a given sensing period, e.g., about 14 days. In certain embodiments, the sensor-derived analyte information is automatically communicated from the sensor electronics assembly to a remote monitor device or display device for output to a user throughout the 14 day period according to a schedule programmed at the on body electronics (e.g., about every 1 minute or about every 5 minutes or about every 10 minutes, or the like). In certain embodiments, sensor-derived analyte information is only communicated from the sensor electronics assembly to a remote monitor device or display device at user-determined times, e.g., whenever a user decides to check analyte information. At such times, a communications system is activated, and sensor-derived information is then sent from the on body electronics to the remote device or display device.
In still other embodiments, the information may be communicated from the first device to the second device automatically and/or continuously when the analyte information is available, and the second device stores or logs the received information without presenting or outputting the information to the user. In such embodiments, the information is received by the second device from the first device when the information becomes available (e.g., when the sensor detects the analyte level according to a time schedule). However, the received information is initially stored in the second device and only output to a user interface or an output component of the second device (e.g., display) upon detection of a request for the information on the second device.
Accordingly, in certain embodiments an inserter as described herein is used to place a sensor electronics assembly on the body so that at least a portion of the in vivo sensor is in contact with bodily fluid such as ISF. Once the sensor is electrically coupled to the electronics unit, sensor derived analyte information may be communicated from the on body electronics to a display device on-demand by powering on the display device (or it may be continually powered), and executing a software algorithm stored in and accessed from a memory of the display device, to generate one or more request commands, control signal or data packet to send to the on body electronics. The software algorithm executed under, for example, the control of the microprocessor or application specific integrated circuit (ASIC) of the display device may include routines to detect the position of the on body electronics relative to the display device to initiate the transmission of the generated request command, control signal and/or data packet.
Display devices may also include programming stored in memory for execution by one or more microprocessors and/or ASICs to generate and transmit the one or more request command, control signal or data packet to send to the on body electronics in response to a user activation of an input mechanism on the display device such as depressing a button on the display device, triggering a soft button associated with the data communication function, and so on. The input mechanism may be alternatively or additionally provided on or in the on body electronics which may be configured for user activation. In certain embodiments, voice commands or audible signals may be used to prompt or instruct the microprocessor or ASIC to execute the software routine(s) stored in the memory to generate and transmit the one or more request command, control signal or data packet to the on body device. In the embodiments that are voice activated or responsive to voice commands or audible signals, on body electronics and/or display devices include a microphone, a speaker, and processing routines stored in the respective memories of the on body electronics and/or the display device to process the voice commands and/or audible signals. In certain embodiments, positioning the on body electronics and the display device within a predetermined distance (e.g., close proximity) relative to each other initiates one or more software routines stored in the memory of the display device to generate and transmit a request command, control signal or data packet.
Different types and/or forms and/or amounts of information may be sent for each on demand reading, including but not limited to one or more of current analyte level information (i.e., real time or the most recently obtained analyte level information temporally corresponding to the time the reading is initiated), rate of change of an analyte over a predetermined time period, rate of the rate of change of an analyte (acceleration in the rate of change), historical analyte information corresponding to analyte information obtained prior to a given reading and stored in memory of the assembly. Some or all of real time, historical, rate of change, rate of rate of change (such as acceleration or deceleration) information may be sent to a display device for a given reading. In certain embodiments, the type and/or form and/or amount of information sent to a display device may be preprogrammed and/or unchangeable (e.g., preset at manufacturing), or may not be preprogrammed and/or unchangeable so that it may be selectable and/or changeable in the field one or more times (e.g., by activating a switch of the system, etc.). Accordingly, in certain embodiments, for each on demand reading, a display device will output a current (real time) sensor-derived analyte value (e.g., in numerical format), a current rate of analyte change (e.g., in the form of an analyte rate indicator such as an arrow pointing in a direction to indicate the current rate), and analyte trend history data based on sensor readings acquired by and stored in memory of on body electronics (e.g., in the form of a graphical trace). Additionally, the on skin or sensor temperature reading or measurement associated with each on demand reading may be communicated from the on body electronics to the display device. The temperature reading or measurement, however, may not be output or displayed on the display device, but rather, used in conjunction with a software routine executed by the display device to correct or compensate the analyte measurement output to the user on the display device.
As described, embodiments include inserters for in vivo analyte sensors and on body electronics that together provide body wearable sensor electronics assemblies. In certain embodiments, in vivo analyte sensors are fully integrated with on body electronics (fixedly connected during manufacture), while in other embodiments they are separate but connectable post manufacture (e.g., before, during or after sensor insertion into a body). On body electronics may include an in vivo glucose sensor, electronics, battery, and antenna encased (except for the sensor portion that is for in vivo positioning) in a waterproof housing that includes or is attachable to an adhesive pad. In certain embodiments, the housing withstands immersion in about one meter of water for up to at least 30 minutes. In certain embodiments, the housing withstands continuous underwater contact, e.g., for longer than about 30 minutes, and continues to function properly according to its intended use, e.g., without water damage to the housing electronics where the housing is suitable for water submersion.
Embodiments include sensor insertion devices, which also may be referred to herein as sensor delivery units, or the like. Insertion devices may retain on body electronics assemblies completely in an interior compartment, i.e., an insertion device may be “pre-loaded” with on body electronics assemblies during the manufacturing process (e.g., on body electronics may be packaged in a sterile interior compartment of an insertion device). In such embodiments, insertion devices may form sensor assembly packages (including sterile packages) for pre-use or new on body electronics assemblies, and insertion devices configured to apply on body electronics assemblies to recipient bodies.
Embodiments include portable handheld display devices, as separate devices and spaced apart from an on body electronics assembly, that collect information from the assemblies and provide sensor derived analyte readings to users. Such devices may also be referred to as meters, readers, monitors, receivers, human interface devices, companions, or the like. Certain embodiments may include an integrated in vitro analyte meter. In certain embodiments, display devices include one or more wired or wireless communications ports such as USB, serial, parallel, or the like, configured to establish communication between a display device and another unit (e.g., on body electronics, power unit to recharge a battery, a PC, etc.). For example, a display device communication port may enable charging a display device battery with a respective charging cable and/or data exchange between a display device and its compatible informatics software.
Compatible informatics software in certain embodiments include, for example, but not limited to stand alone or network connection enabled data management software program, resident or running on a display device, personal computer, a server terminal, for example, to perform data analysis, charting, data storage, data archiving and data communication as well as data synchronization. Informatics software in certain embodiments may also include software for executing field upgradable functions to upgrade firmware of a display device and/or on body electronics unit to upgrade the resident software on the display device and/or the on body electronics unit, e.g., with versions of firmware that include additional features and/or include software bugs or errors fixed, etc. Embodiments may include a haptic feedback feature such as a vibration motor or the like, configured so that corresponding notifications (e.g., a successful on-demand reading received at a display device), may be delivered in the form of haptic feedback.
Embodiments include programming embedded on a computer readable medium, i.e., computer-based application software (may also be referred to herein as informatics software or programming or the like) that processes analyte information obtained from the system and/or user self-reported data. Application software may be installed on a host computer such as a mobile telephone, PC, an Internet-enabled human interface device such as an Internet-enabled phone, personal digital assistant, or the like, by a display device or an on body electronics unit. Informatics programming may transform data acquired and stored on a display device or on body unit for use by a user.
Embodiments of the subject disclosure are described primarily with respect to glucose monitoring devices and systems, and methods of glucose monitoring, for convenience only and such description is in no way intended to limit the scope of the disclosure. It is to be understood that the analyte monitoring system may be configured to monitor a variety of analytes at the same time or at different times.
As described in detail below, embodiments include devices, systems, kits and/or methods to monitor one or more physiological parameters such as, for example, but not limited to, analyte levels, temperature levels, heart rate, or user activity level, over a predetermined monitoring time period. Also provided are methods of manufacturing. Predetermined monitoring time periods may be less than about 1 hour, or may include about 1 hour or more, e.g., about a few hours or more, e.g., about a few days of more, e.g., about 3 or more days, e.g., about 5 days or more, e.g., about 7 days or more, e.g., about 10 days or more, e.g., about 14 days or more, e.g., about several weeks, e.g., about 1 month or more. In certain embodiments, after the expiration of the predetermined monitoring time period, one or more features of the system may be automatically deactivated or disabled at the on body electronics assembly and/or display device.
For example, a predetermined monitoring time period may begin with positioning the sensor in vivo and in contact with a body fluid such as ISF, and/or with the initiation (or powering on to full operational mode) of the on body electronics. Initialization of on body electronics may be implemented with a command generated and transmitted by a display device in response to the activation of a switch and/or by placing the display device within a predetermined distance (e.g., close proximity) to the on body electronics, or by user manual activation of a switch on the on body electronics unit, e.g., depressing a button, or such activation may be caused by the insertion device, e.g., as described in U.S. patent application Ser. No. 12/698,129 filed on Feb. 1, 2010 and U.S. Provisional Application Nos. 61/238,646, 61/246,825, 61/247,516, 61/249,535, 61/317,243, 61/345,562, and 61/361,374, the disclosures of each of which are incorporated herein by reference for all purposes.
When initialized in response to a received command from a display device, the on body electronics retrieves and executes from its memory software routine to fully power on the components of the on body electronics, effectively placing the on body electronics in full operational mode in response to receiving the activation command from the display device. For example, prior to the receipt of the command from the display device, a portion of the components in the on body electronics may be powered by its internal power supply such as a battery while another portion of the components in the on body electronics may be in powered down or maintained in a low power state including no power state, inactive mode, or all components may be in an inactive, powered down mode. Upon receipt of the command, the remaining portion (or all) of the components of the on body electronics is switched to active, fully operational mode.
Embodiments of on body electronics may include one or more printed circuit boards with electronics including control logic implemented in ASIC, microprocessors, memory, and the like, and transcutaneously positionable analyte sensors forming a single assembly. On body electronics may be configured to provide one or more signals or data packets associated with a monitored analyte level upon detection of a display device of the analyte monitoring system within a predetermined proximity for a period of time (for example, about 2 minutes, e.g., 1 minute or less, e.g., about 30 seconds or less, e.g., about 10 seconds or less, e.g., about 5 seconds or less, e.g., about 2 seconds or less) and/or until a confirmation, such as an audible and/or visual and/or tactile (e.g., vibratory) notification, is output on the display device indicating successful acquisition of the analyte related signal from the on body electronics. A distinguishing notification may also be output for unsuccessful acquisition in certain embodiments.
In certain embodiments, the monitored analyte level may be correlated and/or converted to glucose levels in blood or other fluids such as ISF. Such conversion may be accomplished with the on body electronics, but in many embodiments will be accomplished with display device electronics. In certain embodiments, glucose level is derived from the monitored analyte level in the ISF.
Analyte sensors may be insertable into a vein, artery, or other portion of the body containing analyte. In certain embodiments, analyte sensors may be positioned in contact with ISF to detect the level of analyte, where the detected analyte level may be used to infer the user's glucose level in blood or interstitial tissue.
Embodiments include transcutaneous sensors and also wholly implantable sensors and wholly implantable assemblies in which a single assembly including the analyte sensor and electronics are provided in a sealed housing (e.g., hermetically sealed biocompatible housing) for implantation in a user's body for monitoring one or more physiological parameters.
Embodiments include analyte monitors that are provided in small, lightweight, battery-powered and electronically-controlled systems. Such systems may be configured to detect physical parameters of subjects, such as signals indicative of in vivo analyte levels using an electrochemical sensor, and collect such signals, with or without processing. Any suitable measurement technique may be used to obtain signals from the sensors, e.g., may detect current, may employ potentiometry, etc. Techniques may include, but are not limited to amperometry, coulometry, and voltammetry. In some embodiments, sensing systems may be optical, colorimetric, and the like. In some embodiments, the portion of the system that performs this initial processing may be configured to provide the raw or at least initially processed data to another unit for further collection and/or processing. Such provision of data may be affected, for example, by a wired connection, such as an electrical, or by a wireless connection, such as an IR or RF connection.
In certain systems, the analyte sensor is in communication with on body electronics. The on body unit may include a housing in which the on body electronics and at least a portion of the sensor are received.
Certain embodiments are modular. The on body unit may be separately provided as a physically distinct assembly from a monitor unit, e.g., which displays or otherwise indicates analyte levels to a user. The on body unit may be configured to provide the analyte levels detected by the sensor and/or other information (such as temperature, sensor life, etc.) over a communication link to the monitor unit. The monitor unit, in some embodiments, may include, e.g., a mobile telephone device, an in vitro glucose meter, a personal digital assistant, or other consumer electronics such as MP3 device, camera, radio, personal computer, etc., or other communication-enabled data-processing device.
The display unit may perform a variety of functions such as but not limited to data storage and/or processing and/or analysis and/or communication, etc., on the received analyte data to generate information pertaining to the monitored analyte levels and/or process the other information. The monitor unit may incorporate a display screen, which can be used, for example, to display measured analyte levels, and/or an audio component such as a speaker to audibly provide information to a user, and/or a vibration device to provide tactile feedback to a user. It is also useful for a user of an analyte-monitoring system to be able to see trend indications (including the magnitude and direction of any ongoing trend, e.g., the rate of change of an analyte or other parameter, and the amount of time a subject is above and/or below a threshold, such as a hypoglycemic and/or hyperglycemic threshold, etc.); such data may be displayed either numerically, or by a visual indicator such as an arrow that may vary in visual attributes, like size, shape, color, animation, or direction. The monitor unit may further be adapted to receive information from or about an in vitro analyte test strip, which may be manually or automatically entered into the monitor unit. In some embodiments, a monitor unit may incorporate an in vitro analyte test strip port and related electronics in order to be able to make discrete (e.g., blood glucose) measurements using an in vitro test strip (see, e.g., U.S. Pat. No. 6,175,752, the disclosure of which is incorporated by reference herein for all purposes).
The modularity of these systems may vary where one or more components may be constructed to be single use and one or more may be constructed to be re-useable. In some embodiments, the sensor is designed to be attachable and detachable from the on body electronics (and the on body unit may be reusable), e.g., so that one or more of the components may be reused one or more times, while in other embodiments, the sensor and on body electronics may be provided as an integrated, undetachable package, which may be designed to be disposable after use, i.e., not re-used.
For purpose of illustration, and not limitation, the inserters described herein may be used in connection with an exemplary analyte monitoring system as depicted in
Also shown in
Referring back to the
In certain embodiments, on body electronics 1100 may be configured to store some or all of the monitored analyte related data received from analyte sensor 14 in a memory during the monitoring time period, and maintain it in memory until the usage period ends. In such embodiments, stored data is retrieved from on body electronics 1100 at the conclusion of the monitoring time period, for example, after removing analyte sensor 14 from the user by detaching on body electronics 1100 from the skin surface where it was positioned during the monitoring time period. In such data logging configurations, real time monitored analyte level is not communicated to display device 1200 during the monitoring period or otherwise transmitted from on body electronics 1100, but rather, retrieved from on body electronics 1100 after the monitoring time period.
In certain embodiments, input component 1210 of display device 1200 may include a microphone and display device 1200 may include software configured to analyze audio input received from the microphone, such that functions and operation of the display device 1200 may be controlled by voice commands. In certain embodiments, an output component of display device 1200 includes a speaker for outputting information as audible signals. Similar voice responsive components such as a speaker, microphone and software routines to generate, process and store voice driven signals may be provided to on body electronics 1100.
In certain embodiments, display 1220 and input component 1210 may be integrated into a single component, for example a display that can detect the presence and location of a physical contact touch upon the display such as a touch screen user interface. In such embodiments, the user may control the operation of display device 1200 by utilizing a set of pre-programmed motion commands, including, but not limited to, single or double tapping the display, dragging a finger or instrument across the display, motioning multiple fingers or instruments toward one another, motioning multiple fingers or instruments away from one another, etc. In certain embodiments, a display includes a touch screen having areas of pixels with single or dual function capacitive elements that serve as LCD elements and touch sensors.
Display device 1200 also includes data communication port 1230 for wired data communication with external devices such as remote terminal (personal computer) 1700, for example. Example embodiments of the data communication port 1230 include USB port, mini USB port, RS-232 port, Ethernet port, Firewire port, or other similar data communication ports configured to connect to the compatible data cables. Display device 1200 may also include an integrated in vitro glucose meter, including in vitro test strip port 1240 to receive an in vitro glucose test strip for performing in vitro blood glucose measurements.
Referring still to
As further shown in
Referring back to
After the positioning of on body electronics 1100 on the skin surface and analyte sensor 14 in vivo to establish fluid contact with ISF (or other appropriate body fluid), on body electronics 1100 in certain embodiments is configured to wirelessly communicate analyte related data (such as, for example, data corresponding to monitored analyte level and/or monitored temperature data, and/or stored historical analyte related data) when on body electronics 1100 receives a command or request signal from display device 1200. In certain embodiments, on body electronics 1100 may be configured to at least periodically broadcast real time data associated with monitored analyte level which is received by display device 1200 when display device 1200 is within communication range of the data broadcast from on body electronics 1100, i.e., it does not need a command or request from a display device to send information.
For example, display device 1200 may be configured to transmit one or more commands to on body electronics 1100 to initiate data transfer, and in response, on body electronics 1100 may be configured to wirelessly transmit stored analyte related data collected during the monitoring time period to display device 1200. Display device 1200 may in turn be connected to a remote terminal 1700 such as a personal computer and functions as a data conduit to transfer the stored analyte level information from the on body electronics 1100 to remote terminal 1700. In certain embodiments, the received data from the on body electronics 1100 may be stored (permanently or temporarily) in one or more memory of the display device 1200. In certain other embodiments, display device 1200 is configured as a data conduit to pass the data received from on body electronics 1100 to remote terminal 1700 that is connected to display device 1200.
Referring still to
Remote terminal 1700 in certain embodiments may include one or more computer terminals located at a physician's office or a hospital. For example, remote terminal 1700 may be located at a location other than the location of display device 1200. Remote terminal 1700 and display device 1200 could be in different rooms or different buildings. Remote terminal 1700 and display device 1200 could be at least about one mile apart, e.g., at least about 100 miles apart, e.g., at least about 1000 miles apart. For example, remote terminal 1700 could be in the same city as display device 1200, remote terminal 1700 could be in a different city than display device 1200, remote terminal 1700 could be in the same state as display device 1200, remote terminal 1700 could be in a different state than display device 1200, remote terminal 1700 could be in the same country as display device 1200, or remote terminal 1700 could be in a different country than display device 1200, for example.
In certain embodiments, a separate, optional data communication/processing device such as data processing module 1600 may be provided in analyte monitoring system 1000. Data processing module 1600 may include components to communicate using one or more wireless communication protocols such as, for example, but not limited to, infrared (IR) protocol, Bluetooth® protocol, Zigbee® protocol, and 802.11 wireless LAN protocol. Additional description of communication protocols including those based on Bluetooth® protocol and/or Zigbee® protocol can be found in U.S. Patent Publication No. 2006/0193375 incorporated herein by reference for all purposes. Data processing module 1600 may further include communication ports, drivers or connectors to establish wired communication with one or more of display device 1200, on body electronics 1100, or remote terminal 1700 including, for example, but not limited to USB connector and/or USB port, Ethernet connector and/or port, FireWire connector and/or port, or RS-232 port and/or connector.
In certain embodiments, data processing module 1600 is programmed to transmit a polling or query signal to on body electronics 1100 at a predetermined time interval (e.g., once every minute, once every five minutes, or the like), and in response, receive the monitored analyte level information from on body electronics 1100. Data processing module 1600 stores in its memory the received analyte level information, and/or relays or retransmits the received information to another device such as display device 1200. More specifically in certain embodiments, data processing module 1600 may be configured as a data relay device to retransmit or pass through the received analyte level data from on body electronics 1100 to display device 1200 or a remote terminal (for example, over a data network such as a cellular or WiFi data network) or both.
In certain embodiments, on body electronics 1100 and data processing module 1600 may be positioned on the skin surface of the user within a predetermined distance of each other (for example, about 1-12 inches, or about 1-10 inches, or about 1-7 inches, or about 1-5 inches) such that periodic communication between on body electronics 1100 and data processing module 1600 is maintained. Alternatively, data processing module 1600 may be worn on a belt or clothing item of the user, such that the desired distance for communication between the on body electronics 1100 and data processing module 1600 for data communication is maintained. In a further aspect, the housing of data processing module 1600 may be configured to couple to or engage with on body electronics 1100 such that the two devices are combined or integrated as a single assembly and positioned on the skin surface. In further embodiments, data processing module 1600 is detachably engaged or connected to on body electronics 1100 providing additional modularity such that data processing module 1600 may be optionally removed or reattached as desired.
Referring again to
In another embodiment, data processing module 1600 transmits a command or signal to on body electronics 1100 to receive the analyte related data in response to a user activation of a switch provided on data processing module 1600 or a user initiated command received from display device 1200. In further embodiments, data processing module 1600 is configured to transmit a command or signal to on body electronics 1100 in response to receiving a user initiated command only after a predetermined time interval has elapsed. For example, in certain embodiments, if the user does not initiate communication within a programmed time period, such as, for example about 5 hours from last communication (or 10 hours from the last communication, or 24 hours from the last communication), the data processing module 1600 may be programmed to automatically transmit a request command or signal to on body electronics 1100. Alternatively, data processing module 1600 may be programmed to activate an alarm to notify the user that a predetermined time period of time has elapsed since the last communication between the data processing module 1600 and on body electronics 1100. In this manner, users or healthcare providers may program or configure data processing module 1600 to provide certain compliance with analyte monitoring regimen, so that frequent determination of analyte levels is maintained or performed by the user.
In certain embodiments, when a programmed or programmable alarm condition is detected (for example, a detected glucose level monitored by analyte sensor 14 that is outside a predetermined acceptable range indicating a physiological condition) which requires attention or intervention for medical treatment or analysis (for example, a hypoglycemic condition, a hyperglycemic condition, an impending hyperglycemic condition or an impending hypoglycemic condition), the one or more output indications may be generated by the control logic or processor of the on body electronics 1100 and output to the user on a user interface of on body electronics 1100 so that corrective action may be timely taken. In addition to or alternatively, if display device 1200 is within communication range, the output indications or alarm data may be communicated to display device 1200 whose processor, upon detection of the alarm data reception, controls the display 1220 to output one or more notification.
In certain embodiments, control logic or microprocessors of on body electronics 1100 include software programs to determine future or anticipated analyte levels based on information obtained from analyte sensor 14, e.g., the current analyte level, the rate of change of the analyte level, the acceleration of the analyte level change, and/or analyte trend information determined based on stored monitored analyte data providing a historical trend or direction of analyte level fluctuation as function time during monitored time period. Predictive alarm parameters may be programmed or programmable in display device 1200, or the on body electronics 1100, or both, and output to the user in advance of anticipating the user's analyte level reaching the future level. This provides the user an opportunity to take timely corrective action.
Information, such as variation or fluctuation of the monitored analyte level as a function of time over the monitored time period providing analyte trend information, for example, may be determined by one or more control logic or microprocessors of display device 1200, data processing module 1600, and/or remote terminal 1700, and/or on body electronics 1100. Such information may be displayed as, for example, a graph (such as a line graph) to indicate to the user the current and/or historical and/or and predicted future analyte levels as measured and predicted by the analyte monitoring system 1000. Such information may also be displayed as directional arrows (for example, see trend or directional arrow display 1310) or other icon(s), e.g., the position of which on the screen relative to a reference point indicated whether the analyte level is increasing or decreasing as well as the acceleration or deceleration of the increase or decrease in analyte level. This information may be utilized by the user to determine any necessary corrective actions to ensure the analyte level remains within an acceptable and/or clinically safe range. Other visual indicators, including colors, flashing, fading, etc., as well as audio indicators including a change in pitch, volume, or tone of an audio output and/or vibratory or other tactile indicators may also be incorporated into the display of trend data as means of notifying the user of the current level and/or direction and/or rate of change of the monitored analyte level. For example, based on a determined rate of glucose change, programmed clinically significant glucose threshold levels (e.g., hyperglycemic and/or hypoglycemic levels), and current analyte level derived by an in vivo analyte sensor, the system 1000 may include an algorithm stored on computer readable medium to determine the time it will take to reach a clinically significant level and will output notification in advance of reaching the clinically significant level, e.g., 30 minutes before a clinically significant level is anticipated, and/or 20 minutes, and/or 10 minutes, and/or 5 minutes, and/or 3 minutes, and/or 1 minute, and so on, with outputs increasing in intensity or the like.
Referring again back to
Examples of smart phones include Windows®, Android™, iPhone® operating system, Palm® WebOS™, Blackberry® operating system, or Symbian® operating system based mobile telephones with data network connectivity functionality for data communication over an internet connection and/or a local area network (LAN). PDAs as described above include, for example, portable electronic devices including one or more microprocessors and data communication capability with a user interface (e.g., display/output unit and/or input unit, and configured for performing data processing, data upload/download over the internet, for example. In such embodiments, remote terminal 1700 may be configured to provide the executable application software to the one or more of the communication devices described above when communication between the remote terminal 1700 and the devices are established.
In still further embodiments, executable software applications may be provided over-the-air (OTA) as an OTA download such that wired connection to remote terminal 1700 is not necessary. For example, executable applications may be automatically downloaded as software download to the communication device, and depending upon the configuration of the communication device, installed on the device for use automatically, or based on user confirmation or acknowledgement on the communication device to execute the installation of the application. The OTA download and installation of software may include software applications and/or routines that are updates or upgrades to the existing functions or features of data processing module 1600 and/or display device 1200.
Referring back to remote terminal 1700 of
The analyte sensor 14 of the analyte measurement system 1000 may be used to monitor levels of a wide variety of analytes. Analytes that may be monitored include, for example, acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid-stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. One or more analyte may be monitored by a given sensor. In those embodiments that monitor more than one analyte, the analytes may be monitored at the same or different times, which may use the same on body electronics (e.g., simultaneously) or with different on body electronics.
In one embodiment of the present disclosure, sensor 14 is physically positioned in or on the body of a user whose analyte level is being monitored. Sensor 14 may be configured to continuously sample the analyte level of the user and convert the sampled analyte level, e.g., glucose concentration into a corresponding data signal, e.g., a current or voltage, for input into on body electronics. Alternatively, sensor 14 may be configured to sample analyte levels on demand. The on body electronics may amplify, filter, average, and/or otherwise process signal provided by the sensor.
An embodiment of the sensor 14 is illustrated in
Sensor 14 may include a proximal retention portion 48. The insertion portion 30 and the proximal retention portion 48 are sized and configured to be positioned with a sharp for installation into the skin of a subject, as described herein. In use, the sensor 14 may be configured to bend (e.g., along the line B) and therefore be positioned in two substantially perpendicular, intersecting planes. Such bending may occur prior to or during coupling to the on body electronics as described below. (See
Portions 48 and 52 provide a path for electrical connections, e.g., the conductive traces, between the proximal and distal portions of the sensor. Sensor 14 is further provided with a notch or cut-out 54. Such configuration facilitates the sensor 14 to bend (e.g., along the line indicated by line B) such that retention portion 48 remains upright and therefore be positioned in two substantially perpendicular, intersecting planes, as illustrated in
Embodiments of analyte sensors have been described herein to operate electrochemically, through an arrangement of electrodes having chemical sensing layers applied thereto, by generating an electrical current proportional to the volume of a redox reaction of the analyte (and indicative of analyte concentration), catalyzed by an analyte-specific oxidizing enzyme. Embodiments exist in which the number of electrodes provided to bring about and detect the level of these reactions is two, three, or a greater number. However, other types of sensors may be employed as described herein.
A portion of sensor 14 may be situated above the surface of the skin, with a distal portion 30 penetrating through the skin and into the subcutaneous space in contact with the user's biofluid, such as ISF. Further details regarding the electrochemistry of sensor 14 is provided in U.S. Pat. Nos. 5,264,104; 5,356,786; 5,262,035; 5,320,725; and 6,990,366, each of which is incorporated by reference herein for all purposes.
In some embodiments, the sensor is implantable into a subject's body for a usage period (e.g., a minute or more, at least one day or more, about one to about 30 days or even longer, about three to about fourteen days, about three to about seven days, or in some embodiments, longer periods of up to several weeks) to contact and monitor an analyte present in a biological fluid. In this regard, the sensor can be disposed in a subject at a variety of sites (e.g., abdomen, upper arm, thigh, etc.), including intramuscularly, transcutaneously, intravascularly, or in a body cavity.
In some embodiments, sensor 14 is employed by insertion and/or implantation into a user's body for some usage period. In such embodiments, the substrate may be formed from a relatively flexible material.
While the embodiments illustrated in
Insertion assemblies are provided, which are used to install a medical device to the subject. In some embodiments, an insertion assembly includes an inserter and the medical device itself. The inserter can be configured to insert various medical devices into the subject, such as for example, an analyte sensor, an infusion set, or a cannula. In some embodiments, the inserter can be configured to install a combination of such devices, e.g., a combined sensor/infusion set, etc., at the same or different times or locations. For example, in certain embodiments a given inserter can be configured to install a first device and a second device at different times. In this regard, the inserter can be reusable. For example, an inserter may be modifiable to be used with more than one medical device, to include more than one type of medical device, e.g., by attaching an adapter and/or detaching a portion of an inserter. The inserter can install the medical device in, under, or through the skin of the subject, or place the medical device on the surface of the skin. The medical device can include features or structures, e.g., barbs, tabs, adhesive, etc., to maintain the device in position with respect to the skin after insertion. The inserter device may also be used as a lancet, e.g., to pierce the skin without inserting or installing a medical device.
In some embodiments, an insertion assembly includes an inserter, an analyte sensor, and a power supply. The power supply may be inserted simultaneously with the analyte sensor by the inserter. In other embodiments, the battery is installed after or before installation of the analyte sensor. In such case the power supply may be applied by the inserter or separately. The power supply may be used to provide a current or a potential to the sensor and/or to provide power for communication of one or more signals to the monitor unit.
In some embodiments, an insertion assembly includes an inserter, a medical device such as an analyte sensor, and on body electronics. The on body electronics may be deployed and/or installed simultaneously with the analyte sensor by the inserter. In other embodiments, the on body electronics are installed after or before installation of the analyte sensor. For example, the analyte sensor may be installed by the inserter, and the on body electronics may be subsequently installed.
In some embodiments, the on body electronics provide a voltage or current to the analyte sensor. In some embodiments, the on body electronics process signals provided by the analyte sensor. In further embodiments, the on body electronics may include communications functionality for providing signal relating to signal provided by the analyte sensor to a further component, such as, e.g., a monitor unit, a computer, or other component. In some embodiments, communications circuitry, such as an RFID antenna, is provided. The power supply may be used to power some or all of these functions. In some embodiments, power is provided from the monitor unit, e.g., via inductive coupling.
An inserter can include a plurality of different components. For example, an inserter may include one or more components for advancing a sharp towards the skin of the subject. The sensor and on body electronics may be supported by a support structure, such as a carriage. A driver may be provided for advancing the sharp and/or the analyte sensor/support structure. In some embodiments, the actuator is directly or indirectly coupled to the sharp and/or support structure, such that manual force applied by the user to the actuator is transferred to the sharp and/or support structure. In some embodiments, the applied force drives the sharp and/or support structure between a retracted position (within the inserter) and an advanced position (towards the skin of the subject). In some embodiments, the sensor and on body electronics is maintained in a retracted position prior to installation by contacting projections extending inwardly from a sheath. In accordance with this embodiment, the sensor and on body electronics are temporarily maintained operatively between the support structure and the projections disposed on the interior wall of the sheath.
An inserter can also include one or more components for retracting the sharp, while allowing the analyte sensor and optional on body electronics to remain on the subject. The components for retracting the sharp can include a retractor. It is understood that the retractor and the actuator may be the same structure or include some common components. In some embodiments, the retractor is directly or indirectly coupled to the sharp such that the manual force applied by the user is transferred from the retractor to the sharp to retract the sharp from the skin. In other embodiments, a drive assembly may be provided to retract the sharp. For example, the drive assembly may include a spring, motor, hydraulic piston, etc., to retract the sharp away from the skin of the subject. The drive assembly may also include a linear drive component.
In some embodiments, the retractor withdraws the sharp upon actuation by the user. In such cases, the user actuates the retractor when it is desired to withdraw the sharp. For example, the retractor may include a release switch. Upon activation of the release switch, the drive assembly, e.g., the spring or other driver, retracts the sharp from the skin. In other embodiments, the retractor and the actuator include common components. After activating the actuator to advance the sharp and the analyte sensor, the user releases the actuator, which allows the drive assembly to withdraw the sharp from the skin.
In some embodiments, the retractor withdraws the sharp without further user interaction after actuation of insertion. For example, the inserter may include features or components which automatically retract the sharp upon advancement of the sharp and support structure by a predetermined amount. Inserter devices, in which no further action by the user is required to initiate withdrawal of the sharp after insertion, are referred to herein as having “automatic” withdrawal of the sharp.
One embodiment of a needle hub for an inserter is illustrated in
The distal portion 160 of sharp 124 is illustrated in greater detail in
In another embodiment, a sharp 124 may be formed from a standard hypodermic needle utilizing the method depicted in
Due to the compression step, a user may initially start with a larger diameter hypodermic needle so that the finished sharp 124 will have similar dimensions to the previously described sharps.
The sensor 14, mounted with the on body housing 122, can be disposed within a recess of the carriage 130 such as a concave recess in the carriage 130. Alternatively, the sensor 14, mounted with the on body housing 122, can be disposed between the support structure and one or more projections extending from the wall of the sheath. In yet another alternative, the sensor 14, mounted with the on body housing 122, can be held in position by a releasable friction fit coupling to the sharp 124. In this manner, the carriage need not have a recess within which the sensor mounted with the sensor housing is disposed. In the initial configuration of the inserter, the sharp 124 extends through a longitudinal aperture 168 formed in a carriage 130. In some embodiments, the aperture 168 is appropriately sized, such that neither the sharp 124 nor needle hub 136 is in contact with the carriage 130. Accordingly, the needle hub 136 (and sharp 124) on the one hand, and the carriage 130 (
The insertion portion 30 and proximal retention portion 48 of the sensor 14 are disposed within a longitudinal bore 162 within the sharp 124 (See, e.g.,
An embodiment of an inserter is illustrated in
Inserter 500 includes, a bellows portion 502, a sheath 542, and a removable distal cap 504 for maintaining a sterile environment for the medical device and sharp housed therein. As illustrated in
Inserter 500 is illustrated in cross-sectional view in
As illustrated in
By removing downward force on the actuator portion 514, the bias of spring 546 provides an upward (proximal) force, which permits sharp 524 to withdraw from the skin S of the subject. In some embodiments, bellows 502 may provide the entire upward (proximal) force to withdraw sharp 524 from the skin S.
An exemplary driver apparatus is illustrated in
Another feature of the driver apparatuses described herein is modularity. In some embodiments, the driver apparatus and the inserter may each be capable of independent operation. For example, the inserter may include an actuator button or switch to advance the medical device into the skin of the patient without use of the driver apparatus. The driver apparatus, to the extent provides an actuation capability, may be used with any inserter which has an actuation button that may be contacted by the driver of the driver apparatus. In some embodiments, the modularity allows the driver apparatus to be designed for multiple uses, and the inserter device is capable of a single use. In other embodiments, the inserter is also capable of multiple uses, for example, by replacing the sensor and/or on body housing with each use.
Driver apparatus 3600 includes a housing 3602 for positioning with respect to an inserter. A loading element 3604—longitudinally movable with respect to housing 3602—is provided. In some embodiments, driver apparatus 3600 is provided with an actuator, e.g., rotating cam 3606, which provides automatic actuation of an inserter. In use, arming button 3620 is pressed (in direction of arrow E) to connect rack 3610 with pinion 3612 (
As illustrated in
As illustrated in
Another exemplary driver apparatus for actuation of inserters is illustrated in
As illustrated in
As illustrated in
A driver apparatus for actuation of inserters is illustrated in
As illustrated in
An enhanced view of the actuation of driver apparatus 3800 is depicted in
In order to actuate driver apparatus 3800, a user again pushes loading element 3804. This causes trigger 3810 to move in a downward motion, causing cam 3808 to be released. In some embodiments, loading element 3804 is used to alternately depress arming button 3812 and trigger 3810. Cam 3808 is then driven forward by torsion spring 3814 (
As cam 3808 rotates, it pushes down on actuator 3806 (
With continued reference to
An inserter 2400 in accordance with another exemplary embodiment is illustrated in
With reference to
An exploded view of the components of inserter 2400 is illustrated in
A more detailed view of sharp holder 2408 is shown in
To assemble inserter 2400, sharp 2404 is inserted through an opening in on body housing 122 as shown in
Next, plunger 2405, spring 2406, and housing 2402 are assembled as shown in
The sensor housing assembly shown in
Finally, adhesive patch 218 is placed over the opening of housing 2402 and cap 2412 is snap fit over housing 2402 as shown in
In some embodiments, sharp 2404 is a solid needle. In some embodiments, sharp 2404 is provided with a substantially cylindrical configuration defining an interior bore, e.g., a rigid cylindrical member or a hypodermic-style needle. Sharp 2404 may also be provided with an elongated longitudinal opening or gap in the wall. In some embodiments, sharp 2404 is fabricated from a sheet of metal and folded into a substantially “V,” “U” or “C” configuration in cross-section to define the longitudinal recess.
Depression of plunger 2405 causes distal longitudinal movement of on body housing 122 and sharp 2404 from a proximal position to a distal position. During such downward, distal movement, spring 2406 is further compressed between lip 2418 and bottom surface 2424. Detent 2440 provides a minimum force threshold to overcome before on body housing 122 can continue on its downward distal movement. Beyond a minimum force threshold, detent 2440 is pushed outward by on body housing 122, and on body housing 122 then transitions onto ramp 2442. The friction between on body housing 122 and ramp 2442 of the housing hold the on body housing 122 up against plunger 2405.
As illustrated in
When plunger 2405 reaches a distal position, as shown in
As the subject or some apparatus removes force from plunger 2405, spring 2406 urges plunger 2405 toward its proximal position as shown in
In some embodiments, inserter 2400 may be distributed in a sterilized package 2480 as depicted in
In another embodiment, the sterilized inserter 2400 shown in
Driver apparatus 3900 includes a housing 3902 for positioning with respect to an inserter. A release button 3904—longitudinally movable with respect to housing 3902—is provided. The force exerted by return spring 3906 allows release button 3904 to be moved between a proximal and distal position, as shown in
As illustrated in
Plunger 3910 comprises tabs 3916 (not shown) which confine plunger 3910 to housing 3902. Driver spring 3908 is disposed between the bottom of release button 3904 and the top of plunger 3910. Alternatively, the driver spring 3908 could be around the post shown of plunger 3910 and compressed by the cylinder of button 3904.
As illustrated in
As the subject releases pressure on the button 3904, the return spring 3906 pushes it back to its initial position. As the button 3904 returns, the arms of the button pull the arms of the plunger 3910 back to its initial position, automatically re-engaging the tabs 3916 with the housing 3902 (
An exemplary driver apparatus is illustrated in
Driver apparatus 4000 includes a housing 4004 for positioning with respect to an inserter. An outer button 4002—longitudinally movable with respect to housing 4004—is provided. The force exerted by a return spring (not shown) located between housing 4004 and outer button 4002 allows outer button 3904 to be moved between a proximal and distal position, as shown in
As illustrated in
Outer button 4002 comprises guides 4013 which lock inner button 4008 in position using tabs 4022. Inner button 4008 comprises rails 4015 which allow outer button 4002 to move with respect to housing 4004.
Plunger 4012 comprises tabs 4014 which allow it to be fit into and retained within inner button 4008. Furthermore, plunger 4012 comprises arms 4016 having appendages 4018 with openings that engage ledge 4017 on housing 4004.
To actuate driver apparatus 4000, a subject pushes down on outer button 4002 in the direction of the subject's skin causing return spring 4006 and driver spring 4010 to become compressed as illustrated in
The displacement of appendages 4018 from ledge 4017 allows drive spring 4010 to drive plunger 4012 towards plunger 2405 of inserter 2400 as shown in
To remove sharp 2404 from the subject's skin, the subject must remove pressure from outer button 4002 which allows return spring 4006 to exert upward pressure on outer housing 4004 as shown in
It is understood that the subject matter described herein is not limited to particular embodiments described, as such may, of course, vary. It is also understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present subject matter is limited only by the appended claims.
The present application is a continuation of U.S. patent application Ser. No. 17/077,445, filed Oct. 22, 2020, which is a continuation of U.S. patent application Ser. No. 14/996,751, filed Jan. 15, 2016, now U.S. Pat. No. 10,881,340, which is a continuation of U.S. patent application Ser. No. 13/071,487, filed Mar. 24, 2011, now U.S. Pat. No. 9,265,453, which claims the benefit of U.S. Provisional Application Nos. 61/317,243, filed Mar. 24, 2010; 61/345,562, filed May 17, 2010; 61/361,374, filed Jul. 2, 2010; and 61/411,262, filed Nov. 8, 2010, all of which are incorporated herein by reference in their entireties and for all purposes.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3123790 | Tyler | Mar 1964 | A |
| 3260656 | Ross, Jr. | Jul 1966 | A |
| 3522807 | Millenbach | Aug 1970 | A |
| 3581062 | Aston | May 1971 | A |
| 3653841 | Klein | Apr 1972 | A |
| 3670727 | Reiterman | Jun 1972 | A |
| 3719564 | Lilly, Jr. et al. | Mar 1973 | A |
| 3776832 | Oswin et al. | Dec 1973 | A |
| 3837339 | Aisenberg et al. | Sep 1974 | A |
| 3926760 | Allen et al. | Dec 1975 | A |
| 3949388 | Fuller | Apr 1976 | A |
| 3972320 | Kalman | Aug 1976 | A |
| 3979274 | Newman | Sep 1976 | A |
| 4008717 | Kowarski | Feb 1977 | A |
| 4016866 | Lawton | Apr 1977 | A |
| 4036749 | Anderson | Jul 1977 | A |
| 4055175 | Clemens et al. | Oct 1977 | A |
| 4059406 | Fleet | Nov 1977 | A |
| 4076596 | Connery et al. | Feb 1978 | A |
| 4098574 | Dappen | Jul 1978 | A |
| 4100048 | Pompei et al. | Jul 1978 | A |
| 4120292 | LeBlanc, Jr. et al. | Oct 1978 | A |
| 4129128 | McFarlane | Dec 1978 | A |
| 4151845 | Clemens | May 1979 | A |
| 4168205 | Danninger et al. | Sep 1979 | A |
| 4172770 | Semersky et al. | Oct 1979 | A |
| 4178916 | McNamara | Dec 1979 | A |
| 4206755 | Klein | Jun 1980 | A |
| 4224125 | Nakamura et al. | Sep 1980 | A |
| 4240438 | Updike et al. | Dec 1980 | A |
| 4245634 | Albisser et al. | Jan 1981 | A |
| 4247297 | Berti et al. | Jan 1981 | A |
| 4294258 | Bernard | Oct 1981 | A |
| 4327725 | Cortese et al. | May 1982 | A |
| 4340458 | Lerner et al. | Jul 1982 | A |
| 4344438 | Schultz | Aug 1982 | A |
| 4349728 | Phillips et al. | Sep 1982 | A |
| 4352960 | Dormer et al. | Oct 1982 | A |
| 4356074 | Johnson | Oct 1982 | A |
| 4365637 | Johnson | Dec 1982 | A |
| 4366033 | Richter et al. | Dec 1982 | A |
| 4373527 | Fischell | Feb 1983 | A |
| 4375399 | Havas et al. | Mar 1983 | A |
| 4384586 | Christiansen | May 1983 | A |
| 4390621 | Bauer | Jun 1983 | A |
| 4401122 | Clark, Jr. | Aug 1983 | A |
| 4404066 | Johnson | Sep 1983 | A |
| 4418148 | Oberhardt | Nov 1983 | A |
| 4425920 | Bourland et al. | Jan 1984 | A |
| 4427770 | Chen et al. | Jan 1984 | A |
| 4431004 | Bessman et al. | Feb 1984 | A |
| 4436094 | Cerami | Mar 1984 | A |
| 4440175 | Wilkins | Apr 1984 | A |
| 4450842 | Zick et al. | May 1984 | A |
| 4458686 | Clark, Jr. | Jul 1984 | A |
| 4461691 | Frank | Jul 1984 | A |
| 4469110 | Slama | Sep 1984 | A |
| 4477314 | Richter et al. | Oct 1984 | A |
| 4478976 | Goertz et al. | Oct 1984 | A |
| 4484987 | Gough | Nov 1984 | A |
| 4494950 | Fischell | Jan 1985 | A |
| 4509531 | Ward | Apr 1985 | A |
| 4522690 | Venkatasetty | Jun 1985 | A |
| 4524114 | Samuels et al. | Jun 1985 | A |
| 4526661 | Steckhan et al. | Jul 1985 | A |
| 4527240 | Kvitash | Jul 1985 | A |
| 4534356 | Papadakis | Aug 1985 | A |
| 4538616 | Rogoff | Sep 1985 | A |
| 4543955 | Schroeppel | Oct 1985 | A |
| 4545382 | Higgins et al. | Oct 1985 | A |
| 4552840 | Riffer | Nov 1985 | A |
| 4560534 | Kung et al. | Dec 1985 | A |
| 4571292 | Liu et al. | Feb 1986 | A |
| 4573994 | Fischell et al. | Mar 1986 | A |
| 4581336 | Malloy et al. | Apr 1986 | A |
| 4595011 | Phillips | Jun 1986 | A |
| 4619754 | Niki et al. | Oct 1986 | A |
| 4619793 | Lee | Oct 1986 | A |
| 4627445 | Garcia et al. | Dec 1986 | A |
| 4627842 | Katz | Dec 1986 | A |
| 4627908 | Miller | Dec 1986 | A |
| 4633878 | Bombardieri | Jan 1987 | A |
| 4637403 | Garcia et al. | Jan 1987 | A |
| 4650547 | Gough | Mar 1987 | A |
| 4654197 | Lilja et al. | Mar 1987 | A |
| 4655880 | Liu | Apr 1987 | A |
| 4655885 | Hill et al. | Apr 1987 | A |
| 4671288 | Gough | Jun 1987 | A |
| 4679562 | Luksha | Jul 1987 | A |
| 4680268 | Clark, Jr. | Jul 1987 | A |
| 4682602 | Prohaska | Jul 1987 | A |
| 4684537 | Graetzel et al. | Aug 1987 | A |
| 4685463 | Williams | Aug 1987 | A |
| 4685466 | Rau | Aug 1987 | A |
| 4690675 | Katz | Sep 1987 | A |
| 4698057 | Joishy | Oct 1987 | A |
| 4703756 | Gough et al. | Nov 1987 | A |
| 4711245 | Higgins et al. | Dec 1987 | A |
| 4711247 | Fishman | Dec 1987 | A |
| 4717673 | Wrighton et al. | Jan 1988 | A |
| 4721601 | Wrighton et al. | Jan 1988 | A |
| 4721677 | Clark, Jr. | Jan 1988 | A |
| 4726378 | Kaplan | Feb 1988 | A |
| 4726716 | McGuire | Feb 1988 | A |
| 4729672 | Takagi | Mar 1988 | A |
| 4731726 | Allen, III | Mar 1988 | A |
| 4749985 | Corsberg | Jun 1988 | A |
| 4755173 | Konopka | Jul 1988 | A |
| 4757022 | Shults et al. | Jul 1988 | A |
| 4758323 | Davis et al. | Jul 1988 | A |
| 4759371 | Franetzki | Jul 1988 | A |
| 4759828 | Young et al. | Jul 1988 | A |
| 4764416 | Ueyama et al. | Aug 1988 | A |
| 4776944 | Janata et al. | Oct 1988 | A |
| 4777953 | Ash et al. | Oct 1988 | A |
| 4779618 | Mund et al. | Oct 1988 | A |
| 4781683 | Wozniak et al. | Nov 1988 | A |
| 4781798 | Gough | Nov 1988 | A |
| 4784736 | Lonsdale et al. | Nov 1988 | A |
| 4795707 | Niiyama et al. | Jan 1989 | A |
| 4796634 | Huntsman et al. | Jan 1989 | A |
| 4805624 | Yao et al. | Feb 1989 | A |
| 4813424 | Wilkins | Mar 1989 | A |
| 4815469 | Cohen et al. | Mar 1989 | A |
| 4820399 | Senda et al. | Apr 1989 | A |
| 4822337 | Newhouse et al. | Apr 1989 | A |
| 4830959 | McNeil et al. | May 1989 | A |
| 4832797 | Vadgama et al. | May 1989 | A |
| RE32947 | Dormer et al. | Jun 1989 | E |
| 4840893 | Hill et al. | Jun 1989 | A |
| 4848351 | Finch | Jul 1989 | A |
| 4854322 | Ash et al. | Aug 1989 | A |
| 4871351 | Feingold | Oct 1989 | A |
| 4871440 | Nagata et al. | Oct 1989 | A |
| 4874500 | Madou et al. | Oct 1989 | A |
| 4890620 | Gough | Jan 1990 | A |
| 4894137 | Takizawa et al. | Jan 1990 | A |
| 4895147 | Bodicky et al. | Jan 1990 | A |
| 4897162 | Lewandowski et al. | Jan 1990 | A |
| 4897173 | Nankai et al. | Jan 1990 | A |
| 4909908 | Ross et al. | Mar 1990 | A |
| 4911794 | Parce et al. | Mar 1990 | A |
| 4917800 | Lonsdale et al. | Apr 1990 | A |
| 4919141 | Zier et al. | Apr 1990 | A |
| 4919767 | Vadgama et al. | Apr 1990 | A |
| 4921199 | Villaveces | May 1990 | A |
| 4923586 | Katayama et al. | May 1990 | A |
| 4925268 | Iyer et al. | May 1990 | A |
| 4927516 | Yamaguchi et al. | May 1990 | A |
| 4934369 | Maxwell | Jun 1990 | A |
| 4935105 | Churchouse | Jun 1990 | A |
| 4935345 | Guibeau et al. | Jun 1990 | A |
| 4938860 | Wogoman | Jul 1990 | A |
| 4944299 | Silvian | Jul 1990 | A |
| 4950378 | Nagara | Aug 1990 | A |
| 4953552 | DeMarzo | Sep 1990 | A |
| 4954129 | Giuliani et al. | Sep 1990 | A |
| 4969468 | Byers et al. | Nov 1990 | A |
| 4970145 | Bennetto et al. | Nov 1990 | A |
| 4974929 | Curry | Dec 1990 | A |
| 4986271 | Wilkins | Jan 1991 | A |
| 4988341 | Columbus et al. | Jan 1991 | A |
| 4994167 | Shults et al. | Feb 1991 | A |
| 4995402 | Smith et al. | Feb 1991 | A |
| 5000180 | Kuypers et al. | Mar 1991 | A |
| 5001054 | Wagner | Mar 1991 | A |
| 5013161 | Zaragoza et al. | May 1991 | A |
| 5019974 | Beckers | May 1991 | A |
| 5035860 | Kleingeld et al. | Jul 1991 | A |
| 5036860 | Leigh et al. | Aug 1991 | A |
| 5047044 | Smith et al. | Sep 1991 | A |
| 5050612 | Matsumura | Sep 1991 | A |
| 5055171 | Peck | Oct 1991 | A |
| 5058592 | Whisler | Oct 1991 | A |
| 5070535 | Hochmair et al. | Dec 1991 | A |
| 5082550 | Rishpon et al. | Jan 1992 | A |
| 5082786 | Nakamoto | Jan 1992 | A |
| 5089112 | Skotheim et al. | Feb 1992 | A |
| 5095904 | Seligman et al. | Mar 1992 | A |
| 5101814 | Palti | Apr 1992 | A |
| 5106365 | Hernandez | Apr 1992 | A |
| 5108564 | Szuminsky et al. | Apr 1992 | A |
| 5108889 | Smith et al. | Apr 1992 | A |
| 5109850 | Blanco et al. | May 1992 | A |
| 5120420 | Nankai et al. | Jun 1992 | A |
| 5122925 | Inpyn | Jun 1992 | A |
| 5126034 | Carter et al. | Jun 1992 | A |
| 5133856 | Yamaguchi et al. | Jul 1992 | A |
| 5135003 | Souma | Aug 1992 | A |
| 5140985 | Schroeder et al. | Aug 1992 | A |
| 5141868 | Shanks et al. | Aug 1992 | A |
| 5161532 | Joseph | Nov 1992 | A |
| 5165407 | Wilson et al. | Nov 1992 | A |
| 5174291 | Schoonen et al. | Dec 1992 | A |
| 5190041 | Palti | Mar 1993 | A |
| 5192416 | Wang et al. | Mar 1993 | A |
| 5198367 | Aizawa et al. | Mar 1993 | A |
| 5202261 | Musho et al. | Apr 1993 | A |
| 5205920 | Oyama et al. | Apr 1993 | A |
| 5208154 | Weaver et al. | May 1993 | A |
| 5209229 | Gilli | May 1993 | A |
| 5217595 | Smith et al. | Jun 1993 | A |
| 5229282 | Yoshioka et al. | Jul 1993 | A |
| 5234835 | Nestor et al. | Aug 1993 | A |
| 5238729 | Debe | Aug 1993 | A |
| 5246867 | Lakowicz et al. | Sep 1993 | A |
| 5250439 | Musho et al. | Oct 1993 | A |
| 5262035 | Gregg et al. | Nov 1993 | A |
| 5262305 | Heller et al. | Nov 1993 | A |
| 5264103 | Yoshioka et al. | Nov 1993 | A |
| 5264104 | Gregg et al. | Nov 1993 | A |
| 5264105 | Gregg et al. | Nov 1993 | A |
| 5264106 | McAleer et al. | Nov 1993 | A |
| 5271815 | Wong | Dec 1993 | A |
| 5279294 | Anderson | Jan 1994 | A |
| 5284156 | Schramm et al. | Feb 1994 | A |
| 5285792 | Sjoquist et al. | Feb 1994 | A |
| 5286362 | Hoenes et al. | Feb 1994 | A |
| 5286364 | Yacynych et al. | Feb 1994 | A |
| 5288636 | Pollmann et al. | Feb 1994 | A |
| 5293546 | Tadros et al. | Mar 1994 | A |
| 5293877 | O'Hara et al. | Mar 1994 | A |
| 5299571 | Mastrototaro | Apr 1994 | A |
| 5320098 | Davidson | Jun 1994 | A |
| 5320725 | Gregg et al. | Jun 1994 | A |
| 5322063 | Allen et al. | Jun 1994 | A |
| 5337747 | Neftel | Aug 1994 | A |
| 5340722 | Wolfbeis et al. | Aug 1994 | A |
| 5342789 | Chick et al. | Aug 1994 | A |
| 5352348 | Young et al. | Oct 1994 | A |
| 5356786 | Heller et al. | Oct 1994 | A |
| 5360404 | Novacek et al. | Nov 1994 | A |
| 5368028 | Palti | Nov 1994 | A |
| 5372133 | Hogen Esch | Dec 1994 | A |
| 5372427 | Padovani et al. | Dec 1994 | A |
| 5376251 | Kaneko et al. | Dec 1994 | A |
| 5378628 | Gratzel et al. | Jan 1995 | A |
| 5379238 | Stark | Jan 1995 | A |
| 5387327 | Khan | Feb 1995 | A |
| 5390671 | Lord et al. | Feb 1995 | A |
| 5391250 | Cheney, II et al. | Feb 1995 | A |
| 5395504 | Saurer et al. | Mar 1995 | A |
| 5400782 | Beaubiah | Mar 1995 | A |
| 5408999 | Singh et al. | Apr 1995 | A |
| 5411647 | Johnson et al. | May 1995 | A |
| 5425361 | Fenzlein et al. | Jun 1995 | A |
| 5431160 | Wilkins | Jul 1995 | A |
| 5431921 | Thombre | Jul 1995 | A |
| 5437999 | Diebold et al. | Aug 1995 | A |
| 5462645 | Albery et al. | Oct 1995 | A |
| 5469846 | Khan | Nov 1995 | A |
| 5472317 | Field et al. | Dec 1995 | A |
| 5489414 | Schreiber et al. | Feb 1996 | A |
| 5491474 | Suni et al. | Feb 1996 | A |
| 5494562 | Maley et al. | Feb 1996 | A |
| 5496453 | Uenoyama et al. | Mar 1996 | A |
| 5497772 | Schulman et al. | Mar 1996 | A |
| 5507288 | Bocker et al. | Apr 1996 | A |
| 5509410 | Hill et al. | Apr 1996 | A |
| 5514718 | Lewis et al. | May 1996 | A |
| 5527288 | Gross et al. | Jun 1996 | A |
| 5531878 | Vadgama et al. | Jul 1996 | A |
| 5545191 | Mann et al. | Aug 1996 | A |
| 5549568 | Shields | Aug 1996 | A |
| 5551427 | Altman | Sep 1996 | A |
| 5560357 | Faupei et al. | Oct 1996 | A |
| 5562713 | Silvian | Oct 1996 | A |
| 5565085 | Ikeda et al. | Oct 1996 | A |
| 5567302 | Song et al. | Oct 1996 | A |
| 5568806 | Cheney, II et al. | Oct 1996 | A |
| 5569186 | Lord et al. | Oct 1996 | A |
| 5575563 | Chiu et al. | Nov 1996 | A |
| 5582184 | Erickson et al. | Dec 1996 | A |
| 5582697 | Ikeda et al. | Dec 1996 | A |
| 5582698 | Flaherty et al. | Dec 1996 | A |
| 5584813 | Livingston et al. | Dec 1996 | A |
| 5586553 | Halli et al. | Dec 1996 | A |
| 5589326 | Deng et al. | Dec 1996 | A |
| 5593852 | Heller et al. | Jan 1997 | A |
| 5596150 | Arndt et al. | Jan 1997 | A |
| 5601435 | Quy | Feb 1997 | A |
| 5609575 | Larson et al. | Mar 1997 | A |
| 5613978 | Harding | Mar 1997 | A |
| 5617851 | Lipkovker | Apr 1997 | A |
| 5628310 | Rao et al. | May 1997 | A |
| 5628890 | Carter et al. | May 1997 | A |
| 5632557 | Simons | May 1997 | A |
| 5640954 | Pfeiffer et al. | Jun 1997 | A |
| 5651869 | Yoshioka et al. | Jul 1997 | A |
| 5653239 | Pompei et al. | Aug 1997 | A |
| 5660163 | Schulman et al. | Aug 1997 | A |
| 5665071 | Wyrick | Sep 1997 | A |
| 5665222 | Heller et al. | Sep 1997 | A |
| 5670031 | Hintsche et al. | Sep 1997 | A |
| 5680858 | Hansen et al. | Oct 1997 | A |
| 5682233 | Brinda | Oct 1997 | A |
| 5695623 | Michel et al. | Dec 1997 | A |
| 5708247 | McAleer et al. | Jan 1998 | A |
| 5711001 | Bussan et al. | Jan 1998 | A |
| 5711297 | Iliff et al. | Jan 1998 | A |
| 5711861 | Ward et al. | Jan 1998 | A |
| 5711862 | Sakoda et al. | Jan 1998 | A |
| 5733044 | Rose et al. | Mar 1998 | A |
| 5749656 | Boehm et al. | Mar 1998 | A |
| 5735285 | Albert et al. | Apr 1998 | A |
| 5741211 | Renirie et al. | Apr 1998 | A |
| 5766131 | Kondo et al. | Jun 1998 | A |
| 5771001 | Cobb | Jun 1998 | A |
| 5772586 | Heinonen et al. | Jun 1998 | A |
| 5779665 | Mastrototaro et al. | Jul 1998 | A |
| 5791344 | Schulman et al. | Aug 1998 | A |
| 5800420 | Gross et al. | Sep 1998 | A |
| 5807375 | Gross et al. | Sep 1998 | A |
| 5814020 | Gross | Sep 1998 | A |
| 5820551 | Hill et al. | Oct 1998 | A |
| 5820622 | Gross et al. | Oct 1998 | A |
| 5822715 | Worthington et al. | Oct 1998 | A |
| 5827184 | Netherly et al. | Oct 1998 | A |
| 5840020 | Heinonen et al. | Nov 1998 | A |
| 5842983 | Abel et al. | Dec 1998 | A |
| 5851197 | Marano et al. | Dec 1998 | A |
| 5858001 | Tsals et al. | Jan 1999 | A |
| 5865804 | Bachynsky | Feb 1999 | A |
| 5885211 | Eppstein et al. | Mar 1999 | A |
| 5899855 | Brown | May 1999 | A |
| 5924979 | Sedlow et al. | Jul 1999 | A |
| 5925021 | Castellano et al. | Jul 1999 | A |
| 5931814 | Alex et al. | Aug 1999 | A |
| 5931868 | Gross et al. | Aug 1999 | A |
| 5948006 | Mann | Sep 1999 | A |
| 5951521 | Mastrototaro et al. | Sep 1999 | A |
| 5954643 | Van Antwerp | Sep 1999 | A |
| 5954685 | Tierny | Sep 1999 | A |
| 5957854 | Besson et al. | Sep 1999 | A |
| 5961451 | Reber et al. | Oct 1999 | A |
| 5964993 | Blubaugh, Jr. et al. | Oct 1999 | A |
| 5965380 | Heller et al. | Oct 1999 | A |
| 5971922 | Arita et al. | Oct 1999 | A |
| 5972199 | Heller et al. | Oct 1999 | A |
| 5987353 | Khatchatrian et al. | Nov 1999 | A |
| 5993411 | Choi | Nov 1999 | A |
| 5995860 | Sun et al. | Nov 1999 | A |
| 5997501 | Gross et al. | Dec 1999 | A |
| 6001067 | Shults et al. | Dec 1999 | A |
| 6004278 | Botich et al. | Dec 1999 | A |
| 6017335 | Burnham | Jan 2000 | A |
| 6022368 | Gavronsky et al. | Feb 2000 | A |
| 6024699 | Surwit et al. | Feb 2000 | A |
| 6026321 | Miyata et al. | Feb 2000 | A |
| 6027459 | Shain et al. | Feb 2000 | A |
| 6068399 | Tseng | Mar 2000 | A |
| 6049727 | Crothall | Apr 2000 | A |
| 6056718 | Funderburk et al. | May 2000 | A |
| 6083710 | Heller et al. | Jul 2000 | A |
| 6088608 | Schulman et al. | Jul 2000 | A |
| 6091975 | Daddona et al. | Jul 2000 | A |
| 6091976 | Pfeiffer et al. | Jul 2000 | A |
| 6093172 | Funderburk et al. | Jul 2000 | A |
| 6102896 | Roser | Aug 2000 | A |
| 6103033 | Say et al. | Aug 2000 | A |
| 6117290 | Say et al. | Sep 2000 | A |
| 6119028 | Schulman et al. | Sep 2000 | A |
| 6120676 | Heller et al. | Sep 2000 | A |
| 6121009 | Heller et al. | Sep 2000 | A |
| 6121611 | Lindsay et al. | Sep 2000 | A |
| 6122351 | Schlueter, Jr. et al. | Sep 2000 | A |
| 6134461 | Say et al. | Oct 2000 | A |
| 6143164 | Heller et al. | Nov 2000 | A |
| 6159147 | Lichter et al. | Dec 2000 | A |
| 6162611 | Heller et al. | Dec 2000 | A |
| 6175752 | Say et al. | Jan 2001 | B1 |
| 6186982 | Gross et al. | Feb 2001 | B1 |
| 6200265 | Walsh et al. | Mar 2001 | B1 |
| 6212416 | Ward et al. | Apr 2001 | B1 |
| 6219574 | Cormier et al. | Apr 2001 | B1 |
| 6231531 | Lum et al. | May 2001 | B1 |
| 6248067 | Causey, III et al. | Jun 2001 | B1 |
| 6254536 | DeVito | Jul 2001 | B1 |
| 6254586 | Mann et al. | Jul 2001 | B1 |
| 6275717 | Gross et al. | Aug 2001 | B1 |
| 6283761 | Joao | Sep 2001 | B1 |
| 6283982 | Levaughn et al. | Sep 2001 | B1 |
| 6284478 | Heller et al. | Sep 2001 | B1 |
| 6293925 | Safabash et al. | Sep 2001 | B1 |
| 6295506 | Heinonen et al. | Sep 2001 | B1 |
| 6306104 | Cunningham et al. | Oct 2001 | B1 |
| 6309884 | Cooper et al. | Oct 2001 | B1 |
| 6329161 | Heller et al. | Dec 2001 | B1 |
| 6331244 | Lewis et al. | Dec 2001 | B1 |
| 6338790 | Feldman et al. | Jan 2002 | B1 |
| 6348640 | Navot et al. | Feb 2002 | B1 |
| 6359444 | Grimes | Mar 2002 | B1 |
| 6360888 | McIvor et al. | Mar 2002 | B1 |
| 6366794 | Moussy et al. | Apr 2002 | B1 |
| 6368141 | Van Antwerp et al. | Apr 2002 | B1 |
| 6368274 | Van Antwerp et al. | Apr 2002 | B1 |
| 6377828 | Chaiken et al. | Apr 2002 | B1 |
| 6379301 | Worthington et al. | Apr 2002 | B1 |
| 6409740 | Kuhr et al. | Jun 2002 | B1 |
| 6413393 | Van Antwerp et al. | Jul 2002 | B1 |
| 6418332 | Mastrototaro et al. | Jul 2002 | B1 |
| 6424847 | Mastrototaro et al. | Jul 2002 | B1 |
| 6427088 | Bowman, IV et al. | Jul 2002 | B1 |
| 6437679 | Roques | Aug 2002 | B1 |
| 6440068 | Brown et al. | Aug 2002 | B1 |
| 6445374 | Albert et al. | Sep 2002 | B2 |
| 6478736 | Mault | Nov 2002 | B1 |
| 6482176 | Wich | Nov 2002 | B1 |
| 6484045 | Holker et al. | Nov 2002 | B1 |
| 6484046 | Say et al. | Nov 2002 | B1 |
| 6514718 | Heller et al. | Feb 2003 | B2 |
| 6520326 | McIvor et al. | Feb 2003 | B2 |
| 6522927 | Bishay et al. | Feb 2003 | B1 |
| 6551494 | Heller et al. | Apr 2003 | B1 |
| 6554795 | Lam et al. | Apr 2003 | B2 |
| 6554798 | Mann et al. | Apr 2003 | B1 |
| 6558320 | Causey, III et al. | May 2003 | B1 |
| 6558321 | Burd et al. | May 2003 | B1 |
| 6560471 | Heller et al. | May 2003 | B1 |
| 6561978 | Conn et al. | May 2003 | B1 |
| 6562001 | Lebel et al. | May 2003 | B2 |
| 6564105 | Starkweather et al. | May 2003 | B2 |
| 6565509 | Say et al. | May 2003 | B1 |
| 6571128 | Lebel et al. | May 2003 | B2 |
| 6572566 | Effenhauser | Jun 2003 | B2 |
| 6576101 | Heller et al. | Jun 2003 | B1 |
| 6577899 | Lebel et al. | Jun 2003 | B2 |
| 6579690 | Bonnecaze et al. | Jun 2003 | B1 |
| 6585644 | Lebel et al. | Jul 2003 | B2 |
| 6589229 | Connelly et al. | Jul 2003 | B1 |
| 6591125 | Buse et al. | Jul 2003 | B1 |
| 6595919 | Berner et al. | Jul 2003 | B2 |
| 6605200 | Mao et al. | Aug 2003 | B1 |
| 6605201 | Mao et al. | Aug 2003 | B1 |
| 6607509 | Bobroff et al. | Aug 2003 | B2 |
| 6607543 | Purcell | Aug 2003 | B2 |
| 6610012 | Mault | Aug 2003 | B2 |
| 6633772 | Ford et al. | Oct 2003 | B2 |
| 6635014 | Starkweather et al. | Oct 2003 | B2 |
| 6648821 | Lebel et al. | Nov 2003 | B2 |
| 6654625 | Say et al. | Nov 2003 | B1 |
| 6659948 | Lebel et al. | Dec 2003 | B2 |
| 6666849 | Marshall et al. | Dec 2003 | B1 |
| 6668196 | Villegas et al. | Dec 2003 | B1 |
| 6676290 | Lu | Jan 2004 | B1 |
| 6687546 | Lebel et al. | Feb 2004 | B2 |
| 6689056 | Kilcoyne et al. | Feb 2004 | B1 |
| 6694191 | Starkweather et al. | Feb 2004 | B2 |
| 6695860 | Ward et al. | Feb 2004 | B1 |
| 6699188 | Wessel | Mar 2004 | B2 |
| 6702857 | Brauker et al. | Mar 2004 | B2 |
| 6733446 | Lebel et al. | May 2004 | B2 |
| 6740075 | Lebel et al. | May 2004 | B2 |
| 6741877 | Shults et al. | May 2004 | B1 |
| 6746582 | Heller et al. | Jun 2004 | B2 |
| 6758810 | Lebel et al. | Jul 2004 | B2 |
| 6770030 | Schaupp et al. | Aug 2004 | B1 |
| 6790178 | Mault et al. | Sep 2004 | B1 |
| 6809653 | Mann et al. | Oct 2004 | B1 |
| 6810290 | Lebel et al. | Oct 2004 | B2 |
| 6811533 | Lebel et al. | Nov 2004 | B2 |
| 6811534 | Bowman, IV et al. | Nov 2004 | B2 |
| 6813519 | Lebel et al. | Nov 2004 | B2 |
| 6830551 | Uchigaki et al. | Dec 2004 | B1 |
| 6837858 | Cunningham et al. | Jan 2005 | B2 |
| 6837885 | Koblish et al. | Jan 2005 | B2 |
| 6837988 | Leong et al. | Jan 2005 | B2 |
| 6849052 | Ughigaki et al. | Feb 2005 | B2 |
| 6854882 | Chen | Feb 2005 | B2 |
| 6862465 | Shults et al. | Mar 2005 | B2 |
| 6873268 | Lebel et al. | Mar 2005 | B2 |
| 6881551 | Heller et al. | Apr 2005 | B2 |
| 6892085 | McIvor et al. | May 2005 | B2 |
| 6895265 | Silver | May 2005 | B2 |
| 6931327 | Goode, Jr. et al. | Aug 2005 | B2 |
| 6932894 | Mao et al. | Aug 2005 | B2 |
| 6936006 | Sabra | Aug 2005 | B2 |
| 6942518 | Liamos et al. | Sep 2005 | B2 |
| 6950708 | Bowman, IV et al. | Sep 2005 | B2 |
| 6958705 | Lebel et al. | Oct 2005 | B2 |
| 6959211 | Rule et al. | Oct 2005 | B2 |
| 6968294 | Gutta et al. | Nov 2005 | B2 |
| 6971274 | Olin | Dec 2005 | B2 |
| 6971999 | Py et al. | Dec 2005 | B2 |
| 6974437 | Lebel et al. | Dec 2005 | B2 |
| 6990366 | Say et al. | Jan 2006 | B2 |
| 6997907 | Safabash et al. | Feb 2006 | B2 |
| 6998247 | Monfre et al. | Feb 2006 | B2 |
| 7003336 | Holker et al. | Feb 2006 | B2 |
| 7003340 | Say et al. | Feb 2006 | B2 |
| 7003341 | Say et al. | Feb 2006 | B2 |
| 7024245 | Lebel et al. | Apr 2006 | B2 |
| 7025743 | Mann et al. | Apr 2006 | B2 |
| 7025774 | Freeman et al. | Apr 2006 | B2 |
| 7041068 | Freeman et al. | May 2006 | B2 |
| 7041468 | Drucker et al. | May 2006 | B2 |
| 7052483 | Wojcik | May 2006 | B2 |
| 7056302 | Douglas | Jun 2006 | B2 |
| 7074307 | Simpson et al. | Jul 2006 | B2 |
| 7081195 | Simpson et al. | Jul 2006 | B2 |
| 7097637 | Triplett et al. | Aug 2006 | B2 |
| 7098803 | Mann et al. | Aug 2006 | B2 |
| 7108778 | Simpson et al. | Sep 2006 | B2 |
| 7110803 | Shults et al. | Sep 2006 | B2 |
| 7113821 | Sun et al. | Sep 2006 | B1 |
| 7131984 | Sato et al. | Nov 2006 | B2 |
| 7134999 | Brauker et al. | Nov 2006 | B2 |
| 7136689 | Shults et al. | Nov 2006 | B2 |
| 7171274 | Starkweather et al. | Jan 2007 | B2 |
| 7190988 | Say et al. | Mar 2007 | B2 |
| 7192450 | Brauker et al. | Mar 2007 | B2 |
| 7198606 | Boecker et al. | Apr 2007 | B2 |
| 7207974 | Safabash et al. | Apr 2007 | B2 |
| 7226978 | Tapsak et al. | Jun 2007 | B2 |
| 7228162 | Ward et al. | Jun 2007 | B2 |
| 7276029 | Goode, Jr. et al. | Oct 2007 | B2 |
| 7278983 | Ireland et al. | Oct 2007 | B2 |
| 7297151 | Boecker et al. | Nov 2007 | B2 |
| 7299082 | Feldman et al. | Nov 2007 | B2 |
| 7310544 | Brister et al. | Dec 2007 | B2 |
| 7318816 | Bobroff et al. | Jan 2008 | B2 |
| 7324012 | Mann et al. | Jan 2008 | B2 |
| 7329239 | Safabash et al. | Feb 2008 | B2 |
| 7335294 | Heller et al. | Feb 2008 | B2 |
| 7340287 | Mason et al. | Mar 2008 | B2 |
| 7340309 | Miazga et al. | Mar 2008 | B2 |
| 7354420 | Steil et al. | Apr 2008 | B2 |
| 7364592 | Carr-Brendel et al. | Apr 2008 | B2 |
| 7366556 | Brister et al. | Apr 2008 | B2 |
| 7379765 | Petisce et al. | May 2008 | B2 |
| 7381184 | Funderburk et al. | Jun 2008 | B2 |
| 7402153 | Steil et al. | Jul 2008 | B2 |
| 7407493 | Cane | Aug 2008 | B2 |
| 7416541 | Yuzhakov et al. | Aug 2008 | B2 |
| 7424318 | Brister et al. | Sep 2008 | B2 |
| 7455663 | Bikovsky | Nov 2008 | B2 |
| 7460898 | Brister et al. | Dec 2008 | B2 |
| 7467003 | Brister et al. | Dec 2008 | B2 |
| 7471972 | Rhodes et al. | Dec 2008 | B2 |
| 7494465 | Brister et al. | Feb 2009 | B2 |
| 7497827 | Brister et al. | Mar 2009 | B2 |
| 7519408 | Rasdal et al. | Apr 2009 | B2 |
| 7583990 | Goode, Jr. et al. | Sep 2009 | B2 |
| 7591801 | Brauker et al. | Sep 2009 | B2 |
| 7599726 | Goode, Jr. et al. | Oct 2009 | B2 |
| 7604592 | Freeman et al. | Oct 2009 | B2 |
| 7613491 | Boock et al. | Nov 2009 | B2 |
| 7615007 | Shults et al. | Nov 2009 | B2 |
| 7632228 | Brauker et al. | Dec 2009 | B2 |
| 7637868 | Saint et al. | Dec 2009 | B2 |
| 7640048 | Dobbles et al. | Dec 2009 | B2 |
| 7651596 | Petisce et al. | Jan 2010 | B2 |
| 7654956 | Brister et al. | Feb 2010 | B2 |
| 7657297 | Simpson et al. | Feb 2010 | B2 |
| 7666149 | Simons et al. | Feb 2010 | B2 |
| 7682338 | Griffin | Mar 2010 | B2 |
| 7697967 | Stafford | Apr 2010 | B2 |
| 7699807 | Faust et al. | Apr 2010 | B2 |
| 7711402 | Shults et al. | May 2010 | B2 |
| 7713574 | Brister et al. | May 2010 | B2 |
| 7715893 | Kamath et al. | May 2010 | B2 |
| 7727147 | Osorio et al. | Jun 2010 | B1 |
| 7731657 | Stafford | Jun 2010 | B2 |
| 7736344 | Moberg et al. | Jun 2010 | B2 |
| 7763042 | Iio et al. | Jul 2010 | B2 |
| 7822454 | Alden et al. | Oct 2010 | B1 |
| 7850652 | Liniger et al. | Dec 2010 | B2 |
| 7896844 | Thalmann et al. | Mar 2011 | B2 |
| 7955297 | Radmer et al. | Jun 2011 | B2 |
| 7985203 | Haueter et al. | Jul 2011 | B2 |
| 8172805 | Mogensen et al. | May 2012 | B2 |
| 8262618 | Scheurer | Sep 2012 | B2 |
| 8409145 | Raymond et al. | Apr 2013 | B2 |
| 8870822 | Thalmann et al. | Oct 2014 | B2 |
| 8880138 | Cho | Nov 2014 | B2 |
| 9259175 | Stafford | Feb 2016 | B2 |
| 9295786 | Gottlieb et al. | Mar 2016 | B2 |
| 9566384 | Gyrn et al. | Feb 2017 | B2 |
| 10881340 | Curry | Jan 2021 | B2 |
| 10881341 | Curry | Jan 2021 | B1 |
| 11000216 | Curry | May 2021 | B2 |
| 20010056262 | Cabiri et al. | Dec 2001 | A1 |
| 20020013538 | Teller | Jan 2002 | A1 |
| 20020019022 | Dunn et al. | Feb 2002 | A1 |
| 20020019606 | Lebel et al. | Feb 2002 | A1 |
| 20020022855 | Bobroff et al. | Feb 2002 | A1 |
| 20020023852 | McIvor et al. | Feb 2002 | A1 |
| 20020029058 | LeVaughn et al. | Mar 2002 | A1 |
| 20020042090 | Heller et al. | Apr 2002 | A1 |
| 20020055711 | Lavi et al. | May 2002 | A1 |
| 20020057993 | Maisey et al. | May 2002 | A1 |
| 20020066764 | Perry et al. | Jun 2002 | A1 |
| 20020076966 | Carron et al. | Jun 2002 | A1 |
| 20020082487 | Kollias et al. | Jun 2002 | A1 |
| 20020103499 | Perez et al. | Aug 2002 | A1 |
| 20020106709 | Potts et al. | Aug 2002 | A1 |
| 20020119711 | VanAntwerp et al. | Aug 2002 | A1 |
| 20020128594 | Das et al. | Sep 2002 | A1 |
| 20020130042 | Moerman et al. | Sep 2002 | A1 |
| 20020154050 | Krupp et al. | Oct 2002 | A1 |
| 20020161288 | Shin et al. | Oct 2002 | A1 |
| 20020165462 | Westbrook et al. | Nov 2002 | A1 |
| 20020169369 | Ward et al. | Nov 2002 | A1 |
| 20020198444 | Ughigaki et al. | Dec 2002 | A1 |
| 20030023317 | Brauker et al. | Jan 2003 | A1 |
| 20030023461 | Quintanilla et al. | Jan 2003 | A1 |
| 20030032867 | Crothall et al. | Feb 2003 | A1 |
| 20030032874 | Rhodes et al. | Feb 2003 | A1 |
| 20030042137 | Mao et al. | Mar 2003 | A1 |
| 20030060753 | Starkweather et al. | Mar 2003 | A1 |
| 20030065308 | Lebel et al. | Apr 2003 | A1 |
| 20030069510 | Semler | Apr 2003 | A1 |
| 20030078481 | McIvor et al. | Apr 2003 | A1 |
| 20030078560 | Miller et al. | Apr 2003 | A1 |
| 20030083686 | Freeman et al. | May 2003 | A1 |
| 20030097092 | Flaherty | May 2003 | A1 |
| 20030100040 | Bonnecaze et al. | May 2003 | A1 |
| 20030100821 | Heller et al. | May 2003 | A1 |
| 20030109775 | O'Neil et al. | Jun 2003 | A1 |
| 20030134347 | Heller et al. | Jul 2003 | A1 |
| 20030135333 | Aceti et al. | Jul 2003 | A1 |
| 20030144581 | Conn et al. | Jul 2003 | A1 |
| 20030144608 | Kojima et al. | Jul 2003 | A1 |
| 20030155656 | Chiu et al. | Aug 2003 | A1 |
| 20030168338 | Gao et al. | Sep 2003 | A1 |
| 20030176933 | Lebel et al. | Sep 2003 | A1 |
| 20030187338 | Say et al. | Oct 2003 | A1 |
| 20030199790 | Boecker et al. | Oct 2003 | A1 |
| 20030199910 | Boecker et al. | Oct 2003 | A1 |
| 20030212379 | Bylund et al. | Nov 2003 | A1 |
| 20030217966 | Tapsak et al. | Nov 2003 | A1 |
| 20030225361 | Sabra | Dec 2003 | A1 |
| 20040002682 | Kovelman et al. | Jan 2004 | A1 |
| 20040010207 | Flaherty et al. | Jan 2004 | A1 |
| 20040011671 | Shults et al. | Jan 2004 | A1 |
| 20040040840 | Mao et al. | Mar 2004 | A1 |
| 20040045879 | Shults et al. | Mar 2004 | A1 |
| 20040054263 | Moerman et al. | Mar 2004 | A1 |
| 20040064068 | DeNuzzio et al. | Apr 2004 | A1 |
| 20040064133 | Miller et al. | Apr 2004 | A1 |
| 20040096959 | Steine et al. | May 2004 | A1 |
| 20040106858 | Say et al. | Jun 2004 | A1 |
| 20040106859 | Say et al. | Jun 2004 | A1 |
| 20040116847 | Wall | Jun 2004 | A1 |
| 20040116865 | Bengtsson | Jun 2004 | A1 |
| 20040122353 | Shahmirian et al. | Jun 2004 | A1 |
| 20040122489 | Mazar et al. | Jun 2004 | A1 |
| 20040116866 | Gorman et al. | Jul 2004 | A1 |
| 20040133089 | Kilcoyne et al. | Jul 2004 | A1 |
| 20040133164 | Funderburk | Jul 2004 | A1 |
| 20040135684 | Steinthal et al. | Jul 2004 | A1 |
| 20040138544 | Ward et al. | Jul 2004 | A1 |
| 20040138588 | Saikley et al. | Jul 2004 | A1 |
| 20040138688 | Giraud | Jul 2004 | A1 |
| 20040147996 | Miazga et al. | Jul 2004 | A1 |
| 20040152622 | Keith et al. | Aug 2004 | A1 |
| 20040158207 | Hunn et al. | Aug 2004 | A1 |
| 20040167801 | Say et al. | Aug 2004 | A1 |
| 20040171910 | Moore-Steele | Sep 2004 | A1 |
| 20040171921 | Say et al. | Sep 2004 | A1 |
| 20040176672 | Silver et al. | Sep 2004 | A1 |
| 20040186362 | Brauker et al. | Sep 2004 | A1 |
| 20040186365 | Jin et al. | Sep 2004 | A1 |
| 20040193090 | Lebel et al. | Sep 2004 | A1 |
| 20040199059 | Brauker et al. | Oct 2004 | A1 |
| 20040204687 | Mogensen et al. | Oct 2004 | A1 |
| 20040210122 | Sleburg | Oct 2004 | A1 |
| 20040223985 | Dunfiled et al. | Nov 2004 | A1 |
| 20040225338 | Lebel et al. | Nov 2004 | A1 |
| 20040236200 | Say et al. | Nov 2004 | A1 |
| 20040236251 | Roe et al. | Nov 2004 | A1 |
| 20040254433 | Bandis et al. | Dec 2004 | A1 |
| 20040254434 | Goodnow et al. | Dec 2004 | A1 |
| 20040267300 | Mace | Dec 2004 | A1 |
| 20050003470 | Nelson et al. | Jan 2005 | A1 |
| 20050004494 | Perez et al. | Jan 2005 | A1 |
| 20050006122 | Burnette | Jan 2005 | A1 |
| 20050010269 | Lebel et al. | Jan 2005 | A1 |
| 20050027177 | Shin et al. | Feb 2005 | A1 |
| 20050027180 | Goode, Jr. et al. | Feb 2005 | A1 |
| 20050031689 | Shults et al. | Feb 2005 | A1 |
| 20050043598 | Goode, Jr. et al. | Feb 2005 | A1 |
| 20050070819 | Poux et al. | Mar 2005 | A1 |
| 20050085872 | Yanagihara et al. | Apr 2005 | A1 |
| 20050090607 | Tapsak et al. | Apr 2005 | A1 |
| 20050090850 | Thoes et al. | Apr 2005 | A1 |
| 20050101912 | Faust et al. | May 2005 | A1 |
| 20050106713 | Phan et al. | May 2005 | A1 |
| 20050112169 | Brauker et al. | May 2005 | A1 |
| 20050114068 | Chey et al. | May 2005 | A1 |
| 20050121322 | Say et al. | Jun 2005 | A1 |
| 20050131346 | Douglas | Jun 2005 | A1 |
| 20050131347 | Marano-Ford et al. | Jun 2005 | A1 |
| 20050143635 | Kamath et al. | Jun 2005 | A1 |
| 20050154410 | Conway et al. | Jul 2005 | A1 |
| 20050165404 | Miller | Jul 2005 | A1 |
| 20050173245 | Feldman et al. | Aug 2005 | A1 |
| 20050176136 | Burd et al. | Aug 2005 | A1 |
| 20050182306 | Sloan | Aug 2005 | A1 |
| 20050187720 | Goode, Jr. et al. | Aug 2005 | A1 |
| 20050192557 | Brauker et al. | Sep 2005 | A1 |
| 20050195930 | Spital et al. | Sep 2005 | A1 |
| 20050197554 | Polcha | Sep 2005 | A1 |
| 20050199494 | Say et al. | Sep 2005 | A1 |
| 20050203360 | Brauker et al. | Sep 2005 | A1 |
| 20050222518 | Dib | Oct 2005 | A1 |
| 20050222599 | Czernecki et al. | Oct 2005 | A1 |
| 20050236277 | Imran et al. | Oct 2005 | A9 |
| 20050239154 | Feldman et al. | Oct 2005 | A1 |
| 20050239156 | Drucker et al. | Oct 2005 | A1 |
| 20050241957 | Mao et al. | Nov 2005 | A1 |
| 20050245795 | Goode, Jr. et al. | Nov 2005 | A1 |
| 20050245799 | Brauker et al. | Nov 2005 | A1 |
| 20050245844 | Mace et al. | Nov 2005 | A1 |
| 20050277164 | Drucker et al. | Dec 2005 | A1 |
| 20050283114 | Bresina et al. | Dec 2005 | A1 |
| 20050287620 | Heller et al. | Dec 2005 | A1 |
| 20060001538 | Kraft et al. | Jan 2006 | A1 |
| 20060004303 | Weidenhaupt et al. | Jan 2006 | A1 |
| 20060009727 | O'Mahony et al. | Jan 2006 | A1 |
| 20060010098 | Goodnow et al. | Jan 2006 | A1 |
| 20060015020 | Neale et al. | Jan 2006 | A1 |
| 20060015024 | Brister et al. | Jan 2006 | A1 |
| 20060016700 | Brister et al. | Jan 2006 | A1 |
| 20060019327 | Brister et al. | Jan 2006 | A1 |
| 20060020186 | Brister et al. | Jan 2006 | A1 |
| 20060020187 | Brister et al. | Jan 2006 | A1 |
| 20060020188 | Kamath et al. | Jan 2006 | A1 |
| 20060020189 | Brister et al. | Jan 2006 | A1 |
| 20060020190 | Kamath et al. | Jan 2006 | A1 |
| 20060020191 | Brister et al. | Jan 2006 | A1 |
| 20060020192 | Brister et al. | Jan 2006 | A1 |
| 20060036139 | Brister et al. | Feb 2006 | A1 |
| 20060036140 | Brister et al. | Feb 2006 | A1 |
| 20060036141 | Kamath et al. | Feb 2006 | A1 |
| 20060036142 | Brister et al. | Feb 2006 | A1 |
| 20060036143 | Brister et al. | Feb 2006 | A1 |
| 20060036144 | Brister et al. | Feb 2006 | A1 |
| 20060036145 | Brister et al. | Feb 2006 | A1 |
| 20060047220 | Sakata et al. | Mar 2006 | A1 |
| 20060081469 | Lee | Apr 2006 | A1 |
| 20060129173 | Wilkinson | Jun 2006 | A1 |
| 20060135908 | Liniger et al. | Jun 2006 | A1 |
| 20060155210 | Beckman et al. | Jul 2006 | A1 |
| 20060155317 | List | Jul 2006 | A1 |
| 20060166629 | Reggiardo | Jul 2006 | A1 |
| 20060173444 | Choy et al. | Aug 2006 | A1 |
| 20060189863 | Peyser et al. | Aug 2006 | A1 |
| 20060189939 | Gonnelli et al. | Aug 2006 | A1 |
| 20060195029 | Shults et al. | Aug 2006 | A1 |
| 20060195133 | Freeman et al. | Aug 2006 | A1 |
| 20060200181 | Fukuzawa et al. | Sep 2006 | A1 |
| 20060200970 | Brister et al. | Sep 2006 | A1 |
| 20060222566 | Brauker et al. | Oct 2006 | A1 |
| 20060224171 | Sakata et al. | Oct 2006 | A1 |
| 20060226985 | Goodnow et al. | Oct 2006 | A1 |
| 20060247508 | Fennell | Nov 2006 | A1 |
| 20060253086 | Moberg et al. | Nov 2006 | A1 |
| 20060258929 | Goode, Jr. et al. | Nov 2006 | A1 |
| 20060264888 | Moberg et al. | Nov 2006 | A1 |
| 20060271013 | Triplett et al. | Nov 2006 | A1 |
| 20060276724 | Freeman et al. | Dec 2006 | A1 |
| 20060282042 | Walters et al. | Dec 2006 | A1 |
| 20060287591 | Ocvirk et al. | Dec 2006 | A1 |
| 20070016381 | Kamath et al. | Jan 2007 | A1 |
| 20070027381 | Stafford | Feb 2007 | A1 |
| 20070038044 | Dobbles et al. | Feb 2007 | A1 |
| 20070060814 | Stafford | Mar 2007 | A1 |
| 20070073129 | Shah et al. | Mar 2007 | A1 |
| 20070078320 | Stafford | Apr 2007 | A1 |
| 20070078321 | Mazza et al. | Apr 2007 | A1 |
| 20070078322 | Stafford | Apr 2007 | A1 |
| 20070088377 | Levaughn et al. | Apr 2007 | A1 |
| 20070093754 | Mogensen et al. | Apr 2007 | A1 |
| 20070106135 | Sloan et al. | May 2007 | A1 |
| 20070110124 | Zaragoza et al. | May 2007 | A1 |
| 20070123819 | Mernoe et al. | May 2007 | A1 |
| 20070149875 | Ouyang et al. | Jun 2007 | A1 |
| 20070156094 | Safabash et al. | Jul 2007 | A1 |
| 20070163880 | Woo et al. | Jul 2007 | A1 |
| 20070173706 | Neinast et al. | Jul 2007 | A1 |
| 20070173741 | Deshmukh et al. | Jul 2007 | A1 |
| 20070173761 | Kanderian, Jr. et al. | Jul 2007 | A1 |
| 20070179406 | DeNuzzio et al. | Aug 2007 | A1 |
| 20070191701 | Feldman et al. | Aug 2007 | A1 |
| 20070203407 | Hoss et al. | Aug 2007 | A1 |
| 20070203966 | Brauker et al. | Aug 2007 | A1 |
| 20070213611 | Simpson et al. | Sep 2007 | A1 |
| 20070235331 | Simpson et al. | Oct 2007 | A1 |
| 20070244368 | Bayloff et al. | Oct 2007 | A1 |
| 20070244398 | Lo et al. | Oct 2007 | A1 |
| 20070249922 | Peyser et al. | Oct 2007 | A1 |
| 20070255302 | Koeppel et al. | Nov 2007 | A1 |
| 20080004512 | Funderbunk et al. | Jan 2008 | A1 |
| 20080004573 | Kaufmann et al. | Jan 2008 | A1 |
| 20080009692 | Stafford | Jan 2008 | A1 |
| 20080009805 | Ethelfeld | Jan 2008 | A1 |
| 20080017522 | Heller et al. | Jan 2008 | A1 |
| 20080021666 | Goode, Jr. et al. | Jan 2008 | A1 |
| 20080027474 | Curry et al. | Jan 2008 | A1 |
| 20080029391 | Mao et al. | Feb 2008 | A1 |
| 20080031941 | Pettersson | Feb 2008 | A1 |
| 20080033254 | Kamath et al. | Feb 2008 | A1 |
| 20080033268 | Stafford | Feb 2008 | A1 |
| 20080033318 | Mace et al. | Feb 2008 | A1 |
| 20080039702 | Hayter et al. | Feb 2008 | A1 |
| 20080045824 | Tapsak et al. | Feb 2008 | A1 |
| 20080064937 | McGarraugh et al. | Mar 2008 | A1 |
| 20080064941 | Funderbunk et al. | Mar 2008 | A1 |
| 20080064944 | Van Antwerp et al. | Mar 2008 | A1 |
| 20080065646 | Zhang et al. | Mar 2008 | A1 |
| 20080071156 | Brister et al. | Mar 2008 | A1 |
| 20080083617 | Simpson et al. | Apr 2008 | A1 |
| 20080086042 | Brister et al. | Apr 2008 | A1 |
| 20080086044 | Brister et al. | Apr 2008 | A1 |
| 20080086273 | Shults et al. | Apr 2008 | A1 |
| 20080097246 | Stafford | Apr 2008 | A1 |
| 20080108942 | Brister et al. | May 2008 | A1 |
| 20080112848 | Huffstodt et al. | May 2008 | A1 |
| 20080114280 | Stafford | May 2008 | A1 |
| 20080119707 | Stafford | May 2008 | A1 |
| 20080133702 | Sharma et al. | Jun 2008 | A1 |
| 20080154205 | Wojcik | Jun 2008 | A1 |
| 20080161664 | Mastrototaro et al. | Jul 2008 | A1 |
| 20080167578 | Bryer et al. | Jul 2008 | A1 |
| 20080183061 | Goode, Jr. et al. | Jul 2008 | A1 |
| 20080183399 | Goode, Jr. et al. | Jul 2008 | A1 |
| 20080188731 | Brister et al. | Aug 2008 | A1 |
| 20080189051 | Goode, Jr. et al. | Aug 2008 | A1 |
| 20080194935 | Brister et al. | Aug 2008 | A1 |
| 20080194936 | Goode, Jr. et al. | Aug 2008 | A1 |
| 20080194937 | Goode, Jr. et al. | Aug 2008 | A1 |
| 20080194938 | Brister et al. | Aug 2008 | A1 |
| 20080195049 | Thalmann et al. | Aug 2008 | A1 |
| 20080195232 | Carr-Brendel et al. | Aug 2008 | A1 |
| 20080195967 | Goode, Jr. et al. | Aug 2008 | A1 |
| 20080197024 | Simpson et al. | Aug 2008 | A1 |
| 20080200788 | Brister et al. | Aug 2008 | A1 |
| 20080200789 | Brister et al. | Aug 2008 | A1 |
| 20080200791 | Simpson et al. | Aug 2008 | A1 |
| 20080200897 | Hoss et al. | Aug 2008 | A1 |
| 20080208025 | Shults et al. | Aug 2008 | A1 |
| 20080214481 | Challoner et al. | Sep 2008 | A1 |
| 20080214915 | Brister et al. | Sep 2008 | A1 |
| 20080214918 | Brister et al. | Sep 2008 | A1 |
| 20080228051 | Shults et al. | Sep 2008 | A1 |
| 20080228054 | Shults et al. | Sep 2008 | A1 |
| 20080242961 | Brister et al. | Oct 2008 | A1 |
| 20080255440 | Eilerson et al. | Oct 2008 | A1 |
| 20080262469 | Brister et al. | Oct 2008 | A1 |
| 20080269673 | Butoi et al. | Oct 2008 | A1 |
| 20080275313 | Brister et al. | Nov 2008 | A1 |
| 20080283396 | Wang et al. | Nov 2008 | A1 |
| 20080287764 | Rasdal et al. | Nov 2008 | A1 |
| 20080287765 | Rasdal et al. | Nov 2008 | A1 |
| 20080287766 | Rasdal et al. | Nov 2008 | A1 |
| 20080294096 | Uber et al. | Nov 2008 | A1 |
| 20080296155 | Shults et al. | Dec 2008 | A1 |
| 20080300476 | Stafford | Dec 2008 | A1 |
| 20080306368 | Goode, Jr. et al. | Dec 2008 | A1 |
| 20080306434 | Dobbles et al. | Dec 2008 | A1 |
| 20080306435 | Kamath et al. | Dec 2008 | A1 |
| 20080306444 | Brister et al. | Dec 2008 | A1 |
| 20080312601 | Cane | Dec 2008 | A1 |
| 20080319414 | Yodfat et al. | Dec 2008 | A1 |
| 20090005659 | Kollias et al. | Jan 2009 | A1 |
| 20090012377 | Jennewine et al. | Jan 2009 | A1 |
| 20090012379 | Goode, Jr. et al. | Jan 2009 | A1 |
| 20090018424 | Kamath et al. | Jan 2009 | A1 |
| 20090030294 | Petisce et al. | Jan 2009 | A1 |
| 20090036758 | Brauker et al. | Feb 2009 | A1 |
| 20090036763 | Brauker et al. | Feb 2009 | A1 |
| 20090036915 | Karbowniczek et al. | Feb 2009 | A1 |
| 20090043181 | Brauker et al. | Feb 2009 | A1 |
| 20090043182 | Brauker et al. | Feb 2009 | A1 |
| 20090043525 | Brauker et al. | Feb 2009 | A1 |
| 20090043541 | Brauker et al. | Feb 2009 | A1 |
| 20090043542 | Brauker et al. | Feb 2009 | A1 |
| 20090045055 | Rhodes et al. | Feb 2009 | A1 |
| 20090054866 | Teisen-Simony et al. | Feb 2009 | A1 |
| 20090062633 | Brauker et al. | Mar 2009 | A1 |
| 20090062635 | Brauker et al. | Mar 2009 | A1 |
| 20090069658 | Say et al. | Mar 2009 | A1 |
| 20090069750 | Schraga | Mar 2009 | A1 |
| 20090076356 | Simpson et al. | Mar 2009 | A1 |
| 20090076359 | Peyser | Mar 2009 | A1 |
| 20090076360 | Brister et al. | Mar 2009 | A1 |
| 20090076361 | Kamath et al. | Mar 2009 | A1 |
| 20090082693 | Stafford | Mar 2009 | A1 |
| 20090088614 | Taub | Apr 2009 | A1 |
| 20090088787 | Koike et al. | Apr 2009 | A1 |
| 20090099436 | Brister et al. | Apr 2009 | A1 |
| 20090102678 | Mazza et al. | Apr 2009 | A1 |
| 20090105569 | Stafford | Apr 2009 | A1 |
| 20090124877 | Shariati et al. | May 2009 | A1 |
| 20090124878 | Goode et al. | May 2009 | A1 |
| 20090124879 | Brister et al. | May 2009 | A1 |
| 20090124964 | Leach et al. | May 2009 | A1 |
| 20090124979 | Raymond et al. | May 2009 | A1 |
| 20090131768 | Simpson et al. | May 2009 | A1 |
| 20090131769 | Leach et al. | May 2009 | A1 |
| 20090131776 | Simpson et al. | May 2009 | A1 |
| 20090131777 | Simpson et al. | May 2009 | A1 |
| 20090131860 | Nielsen | May 2009 | A1 |
| 20090137886 | Shariati et al. | May 2009 | A1 |
| 20090137887 | Shariati et al. | May 2009 | A1 |
| 20090143659 | Li et al. | Jun 2009 | A1 |
| 20090143660 | Brister et al. | Jun 2009 | A1 |
| 20090156919 | Brister et al. | Jun 2009 | A1 |
| 20090156924 | Shariati et al. | Jun 2009 | A1 |
| 20090163790 | Brister et al. | Jun 2009 | A1 |
| 20090163791 | Brister et al. | Jun 2009 | A1 |
| 20090171182 | Stafford | Jul 2009 | A1 |
| 20090178459 | Li et al. | Jul 2009 | A1 |
| 20090182217 | Li et al. | Jul 2009 | A1 |
| 20090192366 | Mensinger et al. | Jul 2009 | A1 |
| 20090192380 | Shariati et al. | Jul 2009 | A1 |
| 20090192722 | Shariati et al. | Jul 2009 | A1 |
| 20090192724 | Brauker et al. | Jul 2009 | A1 |
| 20090192745 | Kamath et al. | Jul 2009 | A1 |
| 20090192751 | Kamath et al. | Jul 2009 | A1 |
| 20090198215 | Chong et al. | Aug 2009 | A1 |
| 20090203981 | Brauker et al. | Aug 2009 | A1 |
| 20090204341 | Brauker et al. | Aug 2009 | A1 |
| 20090212766 | Olson et al. | Aug 2009 | A1 |
| 20090216103 | Brister et al. | Aug 2009 | A1 |
| 20090240120 | Mensinger et al. | Sep 2009 | A1 |
| 20090240128 | Mensinger et al. | Sep 2009 | A1 |
| 20090240193 | Mensinger et al. | Sep 2009 | A1 |
| 20090242399 | Kamath et al. | Oct 2009 | A1 |
| 20090242425 | Kamath et al. | Oct 2009 | A1 |
| 20090247855 | Boock et al. | Oct 2009 | A1 |
| 20090247856 | Boock et al. | Oct 2009 | A1 |
| 20090259118 | Feldman et al. | Oct 2009 | A1 |
| 20090259201 | Hwang et al. | Oct 2009 | A1 |
| 20090259202 | Leeflang et al. | Oct 2009 | A1 |
| 20090270765 | Ghesquire et al. | Oct 2009 | A1 |
| 20090287073 | Boock et al. | Nov 2009 | A1 |
| 20090287074 | Shults et al. | Nov 2009 | A1 |
| 20090292184 | Funderburk et al. | Nov 2009 | A1 |
| 20090292185 | Funderburk et al. | Nov 2009 | A1 |
| 20090299155 | Yang et al. | Dec 2009 | A1 |
| 20090299156 | Simpson et al. | Dec 2009 | A1 |
| 20090299162 | Brauker et al. | Dec 2009 | A1 |
| 20090299167 | Seymour | Dec 2009 | A1 |
| 20090299276 | Brauker et al. | Dec 2009 | A1 |
| 20100004597 | Gryn et al. | Jan 2010 | A1 |
| 20100010324 | Brauker et al. | Jan 2010 | A1 |
| 20100010331 | Brauker et al. | Jan 2010 | A1 |
| 20100010332 | Brauker et al. | Jan 2010 | A1 |
| 20100016687 | Brauker et al. | Jan 2010 | A1 |
| 20100016698 | Rasdal et al. | Jan 2010 | A1 |
| 20100022855 | Brauker et al. | Jan 2010 | A1 |
| 20100022863 | Mogensen et al. | Jan 2010 | A1 |
| 20100030038 | Brauker et al. | Feb 2010 | A1 |
| 20100030053 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100030111 | Perriere | Feb 2010 | A1 |
| 20100030484 | Brauker et al. | Feb 2010 | A1 |
| 20100030485 | Brauker et al. | Feb 2010 | A1 |
| 20100036215 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036216 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036222 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036223 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036225 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100036281 | Doi | Feb 2010 | A1 |
| 20100041971 | Goode, Jr. et al. | Feb 2010 | A1 |
| 20100045465 | Brauker et al. | Feb 2010 | A1 |
| 20100049014 | Funderburk et al. | Feb 2010 | A1 |
| 20100049024 | Saint et al. | Feb 2010 | A1 |
| 20100063373 | Kamath et al. | Mar 2010 | A1 |
| 20100069728 | Funderburk et al. | Mar 2010 | A1 |
| 20100076283 | Simpson et al. | Mar 2010 | A1 |
| 20100081908 | Dobbles et al. | Apr 2010 | A1 |
| 20100081910 | Brister et al. | Apr 2010 | A1 |
| 20100087724 | Brauker et al. | Apr 2010 | A1 |
| 20100096259 | Zhang et al. | Apr 2010 | A1 |
| 20100099970 | Shults et al. | Apr 2010 | A1 |
| 20100099971 | Shults et al. | Apr 2010 | A1 |
| 20100100113 | Iio et al. | Apr 2010 | A1 |
| 20100106088 | Yodfat et al. | Apr 2010 | A1 |
| 20100113897 | Brenneman et al. | May 2010 | A1 |
| 20100119693 | Tapsak et al. | May 2010 | A1 |
| 20100121169 | Petisce et al. | May 2010 | A1 |
| 20100145229 | Perez et al. | Jun 2010 | A1 |
| 20100168677 | Gabriel et al. | Jul 2010 | A1 |
| 20100174157 | Brister et al. | Jul 2010 | A1 |
| 20100174158 | Kamath et al. | Jul 2010 | A1 |
| 20100174163 | Brister et al. | Jul 2010 | A1 |
| 20100174164 | Brister et al. | Jul 2010 | A1 |
| 20100174165 | Brister et al. | Jul 2010 | A1 |
| 20100174166 | Brister et al. | Jul 2010 | A1 |
| 20100174167 | Kamath et al. | Jul 2010 | A1 |
| 20100174168 | Goode et al. | Jul 2010 | A1 |
| 20100179401 | Rasdal et al. | Jul 2010 | A1 |
| 20100179402 | Goode et al. | Jul 2010 | A1 |
| 20100179404 | Kamath et al. | Jul 2010 | A1 |
| 20100179408 | Kamath et al. | Jul 2010 | A1 |
| 20100179409 | Kamath et al. | Jul 2010 | A1 |
| 20100185065 | Goode et al. | Jul 2010 | A1 |
| 20100185069 | Brister et al. | Jul 2010 | A1 |
| 20100185070 | Brister et al. | Jul 2010 | A1 |
| 20100185071 | Simpson et al. | Jul 2010 | A1 |
| 20100185072 | Goode et al. | Jul 2010 | A1 |
| 20100185075 | Brister et al. | Jul 2010 | A1 |
| 20100191082 | Brister et al. | Jul 2010 | A1 |
| 20100198033 | Krulevitch et al. | Aug 2010 | A1 |
| 20100198034 | Thomas et al. | Aug 2010 | A1 |
| 20100198035 | Kamath et al. | Aug 2010 | A1 |
| 20100198036 | Kamath et al. | Aug 2010 | A1 |
| 20100204653 | Gryn et al. | Aug 2010 | A1 |
| 20100212583 | Brister et al. | Aug 2010 | A1 |
| 20100214104 | Goode et al. | Aug 2010 | A1 |
| 20100217105 | Yodfat et al. | Aug 2010 | A1 |
| 20100217557 | Kamath et al. | Aug 2010 | A1 |
| 20100223013 | Kamath et al. | Sep 2010 | A1 |
| 20100223022 | Kamath et al. | Sep 2010 | A1 |
| 20100223023 | Kamath et al. | Sep 2010 | A1 |
| 20100228109 | Kamath et al. | Sep 2010 | A1 |
| 20100228497 | Kamath et al. | Sep 2010 | A1 |
| 20100240975 | Goode et al. | Sep 2010 | A1 |
| 20100240976 | Goode et al. | Sep 2010 | A1 |
| 20100261987 | Kamath et al. | Oct 2010 | A1 |
| 20100262201 | He et al. | Oct 2010 | A1 |
| 20100274107 | Boock et al. | Oct 2010 | A1 |
| 20100280341 | Boock et al. | Nov 2010 | A1 |
| 20100286496 | Simpson et al. | Nov 2010 | A1 |
| 20100298684 | Leach et al. | Nov 2010 | A1 |
| 20100324392 | Yee et al. | Dec 2010 | A1 |
| 20100324403 | Brister et al. | Dec 2010 | A1 |
| 20100331642 | Bruce et al. | Dec 2010 | A1 |
| 20100331644 | Neale et al. | Dec 2010 | A1 |
| 20100331647 | Shah et al. | Dec 2010 | A1 |
| 20100331648 | Kamath et al. | Dec 2010 | A1 |
| 20100331653 | Stafford | Dec 2010 | A1 |
| 20100331656 | Mensinger et al. | Dec 2010 | A1 |
| 20100331657 | Mensinger et al. | Dec 2010 | A1 |
| 20110004085 | Mensinger et al. | Jan 2011 | A1 |
| 20110009727 | Mensinger et al. | Jan 2011 | A1 |
| 20110016691 | Alden et al. | Jan 2011 | A1 |
| 20110021889 | Hoss et al. | Jan 2011 | A1 |
| 20110024043 | Boock et al. | Feb 2011 | A1 |
| 20110024307 | Simpson et al. | Feb 2011 | A1 |
| 20110027127 | Simpson et al. | Feb 2011 | A1 |
| 20110027453 | Boock et al. | Feb 2011 | A1 |
| 20110027458 | Boock et al. | Feb 2011 | A1 |
| 20110028815 | Simpson et al. | Feb 2011 | A1 |
| 20110028816 | Simpson et al. | Feb 2011 | A1 |
| 20110040256 | Bobroff et al. | Feb 2011 | A1 |
| 20110040263 | Hordum et al. | Feb 2011 | A1 |
| 20110046456 | Hordum | Feb 2011 | A1 |
| 20110046467 | Simpson et al. | Feb 2011 | A1 |
| 20110054275 | Stafford | Mar 2011 | A1 |
| 20110060196 | Stafford | Mar 2011 | A1 |
| 20110073475 | Kastanos et al. | Mar 2011 | A1 |
| 20110077490 | Simpson et al. | Mar 2011 | A1 |
| 20110082484 | Saravia et al. | Apr 2011 | A1 |
| 20110087196 | Hunn et al. | Apr 2011 | A1 |
| 20110106126 | Love et al. | May 2011 | A1 |
| 20110118579 | Goode et al. | May 2011 | A1 |
| 20110118580 | Goode et al. | May 2011 | A1 |
| 20110124992 | Brauker et al. | May 2011 | A1 |
| 20110124997 | Goode et al. | May 2011 | A1 |
| 20110125410 | Goode et al. | May 2011 | A1 |
| 20110130970 | Goode et al. | Jun 2011 | A1 |
| 20110130971 | Goode et al. | Jun 2011 | A1 |
| 20110130998 | Goode et al. | Jun 2011 | A1 |
| 20110137257 | Gyrn et al. | Jun 2011 | A1 |
| 20110144465 | Shults et al. | Jun 2011 | A1 |
| 20110178378 | Brister et al. | Jul 2011 | A1 |
| 20110178461 | Chong et al. | Jul 2011 | A1 |
| 20110184258 | Stafford | Jul 2011 | A1 |
| 20110190603 | Stafford | Aug 2011 | A1 |
| 20110190614 | Brister et al. | Aug 2011 | A1 |
| 20110191044 | Stafford | Aug 2011 | A1 |
| 20110201910 | Rasdal et al. | Aug 2011 | A1 |
| 20110201911 | Johnson et al. | Aug 2011 | A1 |
| 20110218414 | Kamath et al. | Sep 2011 | A1 |
| 20110218490 | Ocvirk et al. | Sep 2011 | A1 |
| 20110231107 | Brauker et al. | Sep 2011 | A1 |
| 20110231140 | Goode et al. | Sep 2011 | A1 |
| 20110231141 | Goode et al. | Sep 2011 | A1 |
| 20110231142 | Goode et al. | Sep 2011 | A1 |
| 20110253533 | Shults et al. | Oct 2011 | A1 |
| 20110257521 | Fraden | Oct 2011 | A1 |
| 20110257895 | Brauker et al. | Oct 2011 | A1 |
| 20110263958 | Brauker et al. | Oct 2011 | A1 |
| 20110270062 | Goode et al. | Nov 2011 | A1 |
| 20110270158 | Brauker et al. | Nov 2011 | A1 |
| 20110275919 | Petisce et al. | Nov 2011 | A1 |
| 20110290645 | Brister et al. | Dec 2011 | A1 |
| 20110313543 | Brauker et al. | Dec 2011 | A1 |
| 20110319729 | Donnay et al. | Dec 2011 | A1 |
| 20110319733 | Stafford | Dec 2011 | A1 |
| 20110319739 | Kamath et al. | Dec 2011 | A1 |
| 20110320130 | Valdes et al. | Dec 2011 | A1 |
| 20120010642 | Lee et al. | Jan 2012 | A1 |
| 20120035445 | Boock et al. | Feb 2012 | A1 |
| 20120040101 | Tapsak et al. | Feb 2012 | A1 |
| 20120046534 | Simpson et al. | Feb 2012 | A1 |
| 20120078071 | Bohm et al. | Mar 2012 | A1 |
| 20120108934 | Valdes et al. | May 2012 | A1 |
| 20120108983 | Banet et al. | May 2012 | A1 |
| 20120123385 | Edwards et al. | May 2012 | A1 |
| 20120143135 | Cole et al. | Jun 2012 | A1 |
| 20120265042 | Neinast et al. | Oct 2012 | A1 |
| 20120296327 | Hutchins et al. | Nov 2012 | A1 |
| 20130047981 | Bacon | Feb 2013 | A1 |
| Number | Date | Country |
|---|---|---|
| 2291105 | Dec 1998 | CA |
| 1202872 | May 2005 | CN |
| 4401400 | Jul 1995 | DE |
| 0320109 | Jun 1989 | EP |
| 0353328 | Feb 1990 | EP |
| 0390390 | Oct 1990 | EP |
| 0396788 | Nov 1990 | EP |
| 0286118 | Jan 1995 | EP |
| 1048264 | Nov 2000 | EP |
| 1177802 | Feb 2002 | EP |
| 1704889 | Sep 2006 | EP |
| 0987982 | Jan 2007 | EP |
| 2060284 | May 2009 | EP |
| 2201969 | Jun 2010 | EP |
| 2327362 | Jun 2011 | EP |
| 2335587 | Jun 2011 | EP |
| 11-506629 | Jun 1999 | JP |
| 2004-033438 | Feb 2004 | JP |
| 2004-520103 | Jul 2004 | JP |
| 2004-520898 | Jul 2004 | JP |
| 2006527036 | Nov 2006 | JP |
| 2007510499 | Apr 2007 | JP |
| 2008506468 | Mar 2008 | JP |
| WO-1991015993 | Oct 1991 | WO |
| WO-1992013271 | Aug 1992 | WO |
| WO-1994020602 | Sep 1994 | WO |
| WO-1996039977 | May 1996 | WO |
| WO-1996025089 | Aug 1996 | WO |
| WO-1998035053 | Aug 1998 | WO |
| WO-1998056293 | Dec 1998 | WO |
| WO-1999033504 | Jul 1999 | WO |
| WO-1999056613 | Nov 1999 | WO |
| WO-2000049940 | Aug 2000 | WO |
| WO-2000059370 | Oct 2000 | WO |
| WO-2000078992 | Dec 2000 | WO |
| WO-2001052935 | Jul 2001 | WO |
| WO-2001054753 | Aug 2001 | WO |
| WO-2002016905 | Feb 2002 | WO |
| WO-2002050534 | Jun 2002 | WO |
| WO-2002058537 | Aug 2002 | WO |
| WO 03026728 | Apr 2003 | WO |
| WO-2003028784 | Apr 2003 | WO |
| WO-2003076893 | Sep 2003 | WO |
| WO-2003082091 | Oct 2003 | WO |
| WO-2004028337 | Apr 2004 | WO |
| WO-2004060436 | Jul 2004 | WO |
| WO-2004061420 | Jul 2004 | WO |
| WO-2004098684 | Nov 2004 | WO |
| WO-2004112602 | Dec 2004 | WO |
| WO-2005084534 | Sep 2005 | WO |
| WO-2005089103 | Sep 2005 | WO |
| WO-2006024671 | Mar 2006 | WO |
| WO-2006042811 | Apr 2006 | WO |
| WO-2006108809 | Oct 2006 | WO |
| WO 2006110742 | Oct 2006 | WO |
| WO 2006121921 | Nov 2006 | WO |
| WO-2007089738 | Aug 2007 | WO |
| WO-2007140783 | Dec 2007 | WO |
| WO 2008065646 | Jun 2008 | WO |
| WO 2008133702 | Nov 2008 | WO |
| WO 2008155377 | Dec 2008 | WO |
| WO 2009016638 | Feb 2009 | WO |
| WO 2009039013 | Mar 2009 | WO |
| WO-2009062675 | May 2009 | WO |
| WO-2009068661 | Jun 2009 | WO |
| WO 2010112521 | Oct 2010 | WO |
| WO-2011002815 | Jan 2011 | WO |
| Entry |
|---|
| Alcock & Turner, “Continuous analyte monitoring to aid clinical practice,” IEEE Engineering in Medicine & BioloXY Magazine, 13:319-25 (1994). |
| Armour et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs,” Diabetes, vol. 39, pp. 1519-1526, Dec. 1990. |
| Bindra, D.S. et al., “Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring,” Anal. Chem., 63(17):1692-1696 (Sep. 1, 1991). |
| Bobbioni-Harsch, E. et al., “Lifespan of subcutaneous glucose sensors and their performances during dynamic glycaemia changes in rats,” J. Biomed. Eng. 15:457-463 (1993). |
| Cass, A.E.G. et al., “Ferrocene-Mediated Enzyme Electrode for Amperometric Determination of Glucose,” Anal. Chem., 56(4):667-671 (Apr. 1984). |
| Gregg, B. A. et al., “Cross-Linked Redox Gels Containing Glucose Oxidase for Amperometric Biosensor Applications,” Analytical Chemistry, 62(3):258-263 (Feb. 1, 1990). |
| Harrison, DJ. et al., “Characterization of Perfluorosulfonic Acid Polymer Coated Enzyme Electrodes and a Miniaturized Integrated Potentiostat for Glucose Analysis in Whole Blood,” Anal. Chem., 60 (19):2002-2007 (Oct. 1, 1988). |
| Heller, A., “Electrical Connection of Enzyme Redox Centers to Electrodes,” J. Phys. Chem., 96 (9):3579-3587 (1992). |
| Heller, A., “Electrical Wiring of Redox Enzymes,” Acc. Chem. Res., 23(5):129-134 (1990). |
| International Search Report and Written Opinion from PCT/US2010/022860 dated Mar. 23, 2010. |
| International Search Report and Written Opinion from PCT/US2010/047381 dated Oct. 15, 2010. |
| International Search Report and Written Opinion from PCT/US2010/050772 dated Dec. 3, 2010. |
| International Search Report and Written Opinion from PCT/US2010/050888 dated Nov. 29, 2010. |
| International Search Report and Written Opinion from PCT/US2010/051861 dated Nov. 30, 2010. |
| Johnson, K., et al., “In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue,” Biosensors and Bioelectronics. 1992, vol. 7, pp. 709-714. |
| Maidan, R. et al., “Elimination of Electroaxidizable Interferant-Produced Currents in Amperometric Biosensors,” Analytical Chemistry, 64(23):2889-2896 (Dec. 1, 1992). |
| Mastrototaro, J.J., et al., “An Electroenzymatic Glucose Sensor Fabricated on a Flexible Substrate,” Sensors and Biosensors B Chemical, B5: 139-144 (1991). |
| McKean, B., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors,” IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, (Jul. 1988), pp. 526-532. |
| Moatti-Sirat, D., et al., “Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue,” Diabetolocia, 35(3) (1 page—Abstract only) (Mar. 1992). |
| Ohara, T. J., et al., “Glucose Electrodes Based on Cross-Linked [Os(bpy)2Cl]+/2+ Complexed Poly(1-vinylimadazole) Films,” Analytical Chemistry, 65(23):3512-3516 (Dec. 1, 1993). |
| Opinion of the Court, Supreme Court of the United States, No. 04-1350, KSR International co., Petitioner v. Teleflex Inc. et al., Apr. 30, 2007. |
| Pickup, J. C., et al., “In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer,” Diabetologia, 32(3):213-217 (1989). |
| Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels,” Anal. Chem., 63(20):2268-2272 (Oct. 15, 1991). |
| Poitout, V., et al., “In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor,” ASAIO Transactions, 37(3) (1 page—Abstract only) (Jul.-Sep. 1991). |
| Reach, G., et al., “Can Continuous Glucose Monitoring Be Used for the Treatment of Diabetes?,” Analytical Chemistry, 64(6):381-386 (Mar. 15, 1992). |
| Rebrin, K., et al., “Automated Feedback Control of Subcutaneous Glucose Concentration in Diabetic Dogs,” Diabetologia, 32(8):573-576 (Aug. 1989). |
| Sakakida, M., et al., “Ferrocene-mediate needle-type glucose sensor covered with newly designed biocompatible membrane,” Sensors and Actuators B, 13-14:319-322 (1993). |
| Sakakida, M., et al., “Development of ferrocene-mediated needle-type glucose sensor as a measure of true subcutaneous tissue glucose concentrations”, Artif Organs Today. 1992, vol. 2, No. 2, pp. 145-458. |
| Shichiri, M., et al., “Glycaemic Control in Pancrearetomized Dogs with a Wearable Artificial Endocrine Pancreas,” Diabetologia, 24(3):179-184 (Mar. 1983). |
| Shichiri, M., et al., “Telemetry Glucose Monitoring Device with Needle-type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals,” Diabetes Care, vol. 9, No. 3 (May-Jun. 1986), pp. 298-301. |
| Shichiri, M., et al., “In vivo characteristics of needle-type glucose sensor—Measurement of subcutaneous glucose concentrations in human volunteers,” Horm Metab Res Suppl. 1988, vol. 20, pp. 17-20. |
| Shichiri, M., et al., “Wearable artificial endocrine pancreas with needle-type glucose sensor,” The Lancet, 1982, vol. 2, No. 8308, pp. 1129-1131. |
| Shults, M., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors,” IEEE Transactions on Biomedical Engineering, vol. 41, No. 10 (Oct. 1994), pp. 937-942. |
| Sternberg, R., et al., “Study and Development of Multilayer Needle-type Enzyme-based Glucose Microsensors,” Biosensors, 4:27-40 (1988). |
| Turner, A.P.F., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors, 1:85-115 (1985). |
| Updike, S. et al., “Principles of Long-term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucase from Inside a Subcataneous Foreign Body Capsule (FBC)” in “Biosensors in the Body: Continuous in vivo Monitoring” (John Wiley & Sons, Ltd., 1997) Chapter 4, pp. 117-137. |
| Velho, G. et al., “Strategies for calibrating a subcutaneous glucose sensor,” Biomed. Biochim. Acta, 48 (11112):957-964 (1989). |
| Wilson, G. S. et al., “Progress toward the Development of an Implantable Sensor for Glucose,” Clinical Chemistry, 38(9):1613-1617 (1992). |
| Ye, L. et al., “High Current Density “Wired” Quinoprotein Glucose Dehydrogenase Electroade,” Anal. Chem., 65(3):238-241 (Feb. 1, 1993). |
| Extended Search Report for European Appl. No. 16176370.1 dated Dec. 7, 2016. |
| Office Action for Japanese Appl. No. 2016-44196 dated Apr. 11, 2017. |
| Extended Search Report for European Appl. No. 19184881.1 dated Dec. 4, 2019. |
| Aussedat, B., et al., “A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycemic Alarm”, Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071. |
| Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33. |
| Claremont, D. J., et al., “Biosensors for Continuous In Vivo Glucose Monitoring”, Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988. |
| Clark Jr., L. C., et al., “Electrode Systems for Continuous Monitoring in Cardiovascular Surgery”, Annals New York Academy of Sciences, 1962, pp. 29-45. |
| Clark Jr., L. C., et al., “Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice”, American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265. |
| Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244. |
| Csoregi, E., et al., “Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode”, Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138. |
| Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779. |
| Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004. |
| Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652. |
| Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719. |
| Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, pp. 198. |
| Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, 2002, pp. 250. |
| Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304. |
| Koudelka, M., et al., “In-Vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 31-36. |
| Lager, W., et al., “Implantable Electrocatalytic Glucose Sensor”, Hormone Metabolic Research, vol. 26, 1994, pp. 526-530. |
| Moatti-Sirat, D., et al., “Evaluating In Vitro and In Vivo the Interference of Ascorbate and Acetaminophen on Glucose Detection by a Needle-Type Glucose Sensor”, Biosensors & Bioelectronics, vol. 7, 1992, pp. 345-352. |
| Moatti-Sirat, D., et al., “Reduction of Acetaminophen Interference in Glucose Sensors by a Composite Nafion Membrane: Demonstration in Rats and Man”, Diabetologia, vol. 37, 1994, pp. 610-616. |
| Olievier, C. N., et al., “In Vivo Measurement of Carbon Dioxide Tension with a Miniature Electrodes”, Pflugers Archiv: European Journal of Physiology, vol. 373, 1978, pp. 269-272. |
| Pickup, J., “Developing Glucose Sensors for In Vivo Use”, Tibtech, vol. 11, 1993, pp. 285-291. |
| Pickup, J., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88, pp. 335-346. |
| Pickup, J., et al., “Potentially-Implantable, Amperometric Glucose Sensors with Mediated Electron Transfer: Improving the Operating Stability”, Biosensors, vol. 4, 1989, pp. 109-119. |
| Poitout, V., et al., “A Glucose Monitoring System for On Line Estimation in Man of Blood Glucose Concentration Using a Miniaturized Glucose Sensor Implanted in the Subcutaneous Tissue and a Wearable Control Unit”, Diabetolgia, vol. 36, 1993, pp. 658-663. |
| Poitout, V., et al., “Calibration in Dogs of a Subcutaneous Miniaturized Glucose Sensor Using a Glucose Meter for Blood Glucose Determination”, Biosensors & Bioelectronics, vol. 7, 1992, pp. 587-592. |
| Quinn, C. P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors”, The American Physiological Society, 1995, E155-E161. |
| Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241. |
| Salehi, C., et al., “A Telemetry-Instrumentation Systems for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308. |
| Scheller, F., et al., “Enzyme Electrodes and Their Application”, Philosophical Transactions of the Royal Society of London B, vol. 316, 1987, pp. 85-94. |
| Schmidt, F. J., et al., “Calibration of a Wearable Glucose Sensor”, The International Journal of Artificial Organs, vol. 15, No. 1, 1992, pp. 55-61. |
| Schmidtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299. |
| Shaw, G. W., et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406. |
| Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313. |
| Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210. |
| Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261. |
| Velho, G., et al., “In Vitro and In Vivo Stability of Electrode Potentials in Needle-Type Glucose Sensors”, Diabetes, vol. 38, No. 2, 1989, pp. 164-171. |
| Von Woedtke, T., et al., “In Situ Calibration of Implanted Electrochemical Glucose Sensors”, Biomedica Biochemica Acta, vol. 48, 1989, pp. 943-952. |
| AU 2011269796 Examination Report dated Apr. 3, 2014. |
| CN 201180002616.7 Office Action dated Apr. 24, 2014. |
| CN 201180002617.1 Office Action dated Jul. 3, 2014. |
| EP 11760268.0 Extended European Search Report dated Apr. 14, 2014. |
| PCT Application No. PCT/US2011/029881, International Search Report and Written Opinion dated May 20, 2011. |
| PCT Application No. PCT/US2011/029883, International Search Report and Written Opinion dated Jun. 2, 2011. |
| PCT Application No. PCT/US2011/029884, International Search Report and Written Opinion dated Jun. 1, 2011. |
| Gunasingham, et al., “Electrochemically Modulated Optrode for Glucose”, Biosensors & Bioelectronics, vol. 7, 1992, pp. 353-359. |
| Ikeda, T., et al., “Artificial Pancreas—Investigation of the Stability of Glucose Sensors Using a Telemetry System” (English language translation of abstract), Jpn. J. Artif. Organs, vol. 19, No. 2, 1990, 889-892. |
| Minimed Technologies, “Tape Tips and Other Infusion Site Information”, 1995. |
| Japanese Patent Application No. 2013-501503, Office Action dated Mar. 3, 2015. |
| European Patent Application No. 10739015.5, Extended European Search Report dated May 10, 2013. |
| PCT Application No. PCT/US2010/022860, International Preliminary Report on Patentability and Written Opinion dated Aug. 18, 2011. |
| PCT Application No. PCT/US2010/050772, International Preliminary Report on Patentability and Written Opinion dated Apr. 12, 2012. |
| PCT Application No. PCT/US2010/050888, International Preliminary Report on Patentability and Written Opinion dated Apr. 12, 2012. |
| PCT Application No. PCT/US2010/051861, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Apr. 19, 2012. |
| PCT Application No. PCT/US2011/029881, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Oct. 4, 2012. |
| PCT Application No. PCT/US2011/029883, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Oct. 4, 2012. |
| PCT Application No. PCT/US2012/062551, International Search Report and Written Opinion of the International Searching Authority dated Jan. 2, 2013. |
| PCT Application No. PCT/US2011/029884, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority dated Oct. 4, 2012. |
| Number | Date | Country | |
|---|---|---|---|
| 61411262 | Nov 2010 | US | |
| 61361374 | Jul 2010 | US | |
| 61345562 | May 2010 | US | |
| 61317243 | Mar 2010 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17077445 | Oct 2020 | US |
| Child | 17206013 | US | |
| Parent | 14996751 | Jan 2016 | US |
| Child | 17077445 | US | |
| Parent | 13071487 | Mar 2011 | US |
| Child | 14996751 | US |
